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ABSTRACT 
Dietary supplementation of fish oil has been associated with reduced risk of 
cardiovascular disease. However, previous studies from our lab showed severe 
hyperlipidemia and elevated oxidative stress levels in BioF1B hamsters fed 20% (w/w) 
fish oil supplemented diet. BioF1B hamster, an inbred strain from Bio87.2 and Bio 1.5 
parent strains, is an animal model for diet induced hyperlipidemia and atherosclerosis. 
BioFlB hamsters have significantly lower post-heparin lipoprotein lipase (LPL) activity 
as compared to Golden Syrian hamsters, which is further reduced in response to 20% 
(w/w) fish oil diet. Reduced LPL activity in BioF1B hamsters is believed to interfere 
with the clearance of chylomicron-like particles and thus responsible for fish oil induced 
hyperlipidemia. In the present study we compared the effects of two ro-3 PUF A-rich 
sources, fish oil and seal oil, on regulation of lipid metabolism and oxidative stress in 
BioFl B hamsters. The two marine sources of ro-3 PUF A differ in the intramolecular 
distribution of ro-3 PUFA on their triglyceride (TG) molecules. While EPA and DHA are 
primarily located in sn-2 position in fish oil TG, these are distributed in sn-1 and sn-3 
positions in seal oil TG. Fish oil and seal oil further differ in their fatty acid composition 
with significantly higher levels of DP A and MUF A in seal oil as compared to fish oil. We 
hypothesized that BioF 1 B hamsters will be able to tolerate seal oil better than fish oil due 
to differences in positional distribution of ro-3 PUF A in TG molecule as well as 
differences in the fatty acid composition. Moreover, increased resistance to oxidation has 
been reported with seal oil. Significantly lower plasma and liver lipid levels were 
observed with 20% (w/w) seal oil fed BioF1B hamsters as compared to 20% (w/w) fish 
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oil fed BioFlB hamsters. RT-PCR analysis showed significantly reduced SREBP-lc 
mRNA expression levels in seal oil fed hamsters which can partially explain the 
suppression of lipogenesis in response to dietary seal oil compared to fish oil. Seal oil fed 
BioFlB hamsters also showed significantly lower plasma and liver TBARS levels, thus 
suggesting reduced oxidative stress relative to fish oil fed hamsters. Since fish oil fed 
hamsters showed elevated levels of oxidative stress, we wanted to investigate possible 
beneficial effects of antioxidant supplementation in hamsters fed high fat diets. Berry 
extract rich in anthocyanins has gained prominence as a potent antioxidant in recent 
years. Study of the role of anthocyanin enriched (25% w/w) elderberry extract 
supplementation on plasma lipid levels in marine oil fed BioFlB hamsters also revealed 
significant reduction in all plasma lipid parameters upon addition of elderberry extract to 
respective marine oil fed BioFlB hamsters. While cosupplementation with elderberry 
extract resulted in significantly lower hepatic total cholesterol and cholesterol ester 
concentrations in both fish oil and seal oil fed BioFlB hamsters, reductions in hepatic TG 
and free cholesterol levels was seen in fish oil fed group alone. Moreover, both plasma 
and hepatic TBARS levels showed significant reductions upon elderberry extract 
supplementation in fish oil fed BioF 1 B hamsters. Thus, current fmdings suggest that seal 
oil may confer greater benefits compared to fish oil in lowering lipid and oxidative stress 
levels under certain genetic conditions. Furthermore, co-supplementation of fish oil with 
anthocyanin enriched elderberry extract may be beneficial under these conditions than 
fish oil alone. 
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Chapter 1: Introduction 
1.1 Fish oil in cardiovascular disease 
Dietary fish oil consumption is widely believed to confer beneficial effects in 
cardiovascular disease (CVD). Fish oil first gained attention when Bang and Dyerberg 
(1976) and Kromann and Green (1980) reported low incidence of heart disease in 
Eskimos and Greenland Inuits consuming large doses of fish and marine mammals. Since 
these preliminary observations, epidemiological and clinical studies and research 
initiatives have substantiated a beneficial role of fish oil consumption in heart disease 
(Hirai et al. , 1980; Krornhout eta/., 1995; Harris, 1997; Hu eta/., 2002). Fish and marine 
mammals are a rich source of essential omega-3 polyunsaturated fatty acids ( ro-3 PUF A), 
especially eicosapentaenoic acid (EPA; 20:5) and docosahexaenoic acid (DHA; 22:6). In 
1999, GISSI Prevenzione study, a randomized controlled trial to study the effects of 
dietary ro-3 PUF A supplementation, demonstrated significantly reduced cardiovascular 
mortality in patients who had previously experienced myocardial infarction. Dietary ro-3 
PUF A has a beneficial role in the prevention of arrythmias and sudden cardiac death 
(Jones and Lau, 2002; Lemaitre et a/., 2003). The anti-atherogenic effects of fish oil 
intake have been associated with the hypolipidemic, anti-thrombotic and anti-
atheromatous effects of ro-3 PUF A (Simopoulos, 1999). 
1.2 Beneficial effects of fish oil on lipid and lipoprotein profile 
Hypertriglyceridemia was accepted as an independent risk factor for CVD when a 
meta-analysis of 17 population-based studies revealed a strong correlation between 
elevated triglyceride (TG) concentrations and the risk of CVD (Hokanson and Austin, 
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1996). Alterations in lipid and lipoprotein metabolism, which affect the synthesis, 
secretion and clearance of TG-rich lipoproteins, viz. chylomicrons (CM), very-low 
density- lipoprotein (VLDL) and low density-lipoprotein (LDL) are the major cause of 
hypertriglyceridemia. Fish oil feeding studies m normolipidemic and 
hypertriglyceridemic subjects have consistently demonstrated dramatic reductions in 
plasma TG and the rate of VLDL secretion (Connor et al., 1993; Rambjor et al., 1996; 
Putadechakum et al. , 2005; Harris 1997; Menuet et al., 2005). In addition to lowering 
fasting TG levels, dietary fish oil supplementation also effectively reduces postprandial 
plasma TG concentrations (Sanders et al., 1997; Roche and Gibney, 1996). Moreover, 
significant reduction in postprandial chylomicronernia reported in w-3 PUF A fed rats has 
been attributed to accelerated chylomicron clearance and not to reduced chylomicron 
production/ secretion (Harris et al. , 1997a). The net reduced postprandial lipemic 
response following w-3 PUF A consumption is either due to reduced production/secretion 
or enhanced clearance/uptake of these TG-rich lipoproteins. Thus, fish oil consumption is 
gaining immense popularity in light of its beneficial hypotriglyceridemic effects. 
1.2.1 Mechanisms for the regulation of lipid and lipoprotein metabolism by fish oil 
There are two important postprandial pathways for the metabolism of TG-rich 
lipoproteins. The exogenous pathway involves CM secreted by the intestine, which 
transport dietary TG between the gut and blood and are finally taken up by the liver. The 
second pathway involves the synthesis of hepatic VLDL that transports endogenous TG. 
Circulating VLDL is then converted to low density lipoprotein (LDL), which delivers 
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cholesteryl esters to peripheral tissues and liver (Chan et al., 2004). Thus, the net 
lipoprotein levels in circulation depend on their rates of secretion and removal from the 
plasma. Dietary ro-3 PUF A regulate TG concentrations at various stages of CM and 
VLDL metabolism i.e. assembly, secretion and clearance from circulation. 
Apolipoprotein B (ApoB) is an essential surface apolipoprotein involved in the 
synthesis of both CM and VLDL. While the liver secretes ApoB 100 exclusively, the 
intestine secretes ApoB48, a truncated form of ApoB100. ro-3 PUFA supplementation in 
normolipidemic subjects has revealed reduced absolute concentrations of ApoB48 and 
VLDL ApoB100 (Tinker et al. , 1999; Bordin et al., 1998; Park and Harris 2003). These 
reduced levels may be due to suppression at the level of ApoB synthesis or secretion 
(Tinker et a!. , 1999). Reduced VLDL-ApoB 100 pool size observed in normolipidemic 
males fed fish oil was not accompanied by any alteration in ApoB 1 00 synthesis, but 
showed a significant decrease in VLDL assembly (Bordin et a!. , 1998; Wilkinson et al., 
1998). DHA and EPA have been shown to reduce ApoB secretion by fifty percent in cell 
culture studies using newborn swine enterocytes (Wang et al. , 2001). Significantly 
decreased hepatic secretion of ApoB has been reported in men with visceral obesity and 
hyperlipidemic patients upon fish oil supplementation (Chan et al. , 2003; Shidfar et a!., 
2003). Several fish oil feeding studies have confirmed that ro-3 PUF A reduce ApoB 
secretion by targeting ApoB for post-translational degradation within the rough 
endoplasmic reticulum (Kendrick and Higgins 1999; Fisher et al., 2001). However, other 
studies by Fisher et al. (1998) show that ApoB production was not responsive to fish oil 
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supplementation in hypertriglyceridemic patients with diabetes. Thus, fish oil can have 
variable effects on CMJ VLDL assembly and secretion by influencing ApoB levels. 
In addition to the effects of fish oil feeding on CMJVLDL assembly and secretion, 
hypolipidemia can also result owing to enhanced clearance of CMJVLDL from the 
circulation. The clearance of circulating CMJVLDL involves lipoprotein lipase (LPL) 
which hydrolyses the TG molecules of CM and VLDL to free fatty acids (FF A) and 
glycerol. Fish oil supplementation has yielded conflicting results for the regulation of 
LPL activity. While some studies in normolipidemic and hypertriglyceridemic subjects 
show that there is no effect of ro-3 PUF A from fish oil on LPL activity (Bordin et a!., 
1998; Nozaki eta!. , 1991), others showed an increase in pre-heparin LPL activity during 
the fed state with no effect on post-heparin LPL. The latter study also demonstrated 
reduced CM-TG half lives and decreased CM particle sizes, thus suggesting a role for ro-
3 PUF A supplementation in accelerating CM-TG clearance through increased LPL 
activity (Park and Harris 2003). Insulin resistant rats fed fish oil demonstrated a two-fold 
higher LPL activity in adipose tissue but not in muscle tissue (Peyron-Caso et a!., 2003). 
These findings indicated that fish oil might exert its effects on the regulation of LPL 
activity in a tissue specific manner. 
Upon the action of LPL, CM or VLDL are converted into CM or VLDL remnants 
and are taken up by specific receptors present on the liver. Tissues such as liver, intestine, 
heart and adipose tissue take up FF As via membrane associated fatty acid transporters 
(FAT), e. g. fatty acid translocase CD36 and fatty acid binding protein. Fish oil treatment 
can influence plasma FF A levels by altering the activity of membrane associated FAT. 
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Exposure of skeletal muscle cells to EPA increased the activity ofF AT CD36 compared 
with control cells (Aas et al. , 2006). Thus, fish oil potentially exerts its hypolipidemic 
effects by regulating various metabolic pathways involved in lipid transport and storage. 
1.2.2 Fish oil mediated regulation of gene expression 
Besides regulating metabolic pathways at the enzymatic level, fish oil 
supplementation appears to regulate the expression of various genes involved in lipid 
metabolism. co-3 PUF A has been shown to alter plasma TG levels by regulating the 
expression of genes involved in lipid synthesis and oxidation. Downregulation of hepatic 
genes involved in lipogenesis e.g. Fatty acyl synthase (F AS) and Acetyl CoA carboxylase 
(ACC) has been reported in rodents fed co-3 PUF A (Clarke et al. , 1990; Salati and Clarke 
1986). In addition to the negative regulation of lipogenic genes, co-3 PUF A upregulates 
several hepatic genes involved in fatty acid oxidation and storage, such as fatty acyl CoA 
synthetase (Martin et al. , 1997) and carnitine palrnitoyl transferase-! (Chatelain et a!., 
1996). DHA-fed pigs demonstrated significantly increased liver and muscle acyl-CoA 
oxidase mRNA expression, suggesting that DHA treatment may increase peroxisomal 
fatty acid oxidation in these tissues (Hsu et al. , 2004). Thus, co-3 PUF A exerts a dual 
action on the lipid metabolism by decreasing the expression of lipogenic enzymes and 
activating the genes involved in lipid oxidation and storage. This results in a net negative 
fat balance, attesting to the beneficial role of co-3 PUF A in the management of 
hyperlipidemia (Sampath and Ntambi 2005). 
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Besides regulating the expression of genes involved in lipid synthesis and 
oxidation, ro-3 PUF A have also been shown to alter the expression of genes involved in 
the clearance of lipids. There is evidence for the tissue specific regulation of LPL gene 
expression by ro-3 PUF A. Rats fed fish oil showed significantly higher LPL mRNA 
expression in the epididymal adipose tissue compared with maize oil fed rats, while LPL 
mRNA was higher in perirenal adipose tissue in the maize oil fed rats compared with the 
fish oil fed rats (Murphy et al. , 1993). On the other hand, human studies examining the 
effects of ro-3 PUF A on LPL gene expression in adipose tissue demonstrated no 
significant effect on LPL gene expression (Murphy et al. , 1999a). However, ro-3 PUF A 
have been shown to increase LPL gene expression in the adipose tissue of subjects with 
atherogenic lipoprotein phenotype (Khan et a/. , 2002). These studies suggest tissue-
specific regulation of LPL gene expression by fish oil. 
ro-3 PUF A also regulates the gene expression of specific FAT, which determines 
fatty acid uptake, oxidation and storage. FA T/CD36 mRNA expression was found to 
increase after EPA treatment in human skeletal muscle cells (Aas eta/., 2006). Similarly, 
spontaneously hypertensive rats fed ro-3 PUF A showed increased adipose tissue CD36 
mRNA levels as compared to the control Kyoto-Wistar rats (Aguilera el a/. , 2006). Thus, 
ro-3 PUF A appears to regulate plasma TG concentrations by altering lipid transport and 
storage pathways at the molecular level. 
Recently, eDNA microarrays have been used to study the effects of ro-3 PUF A on 
the transcription of hepatic genes involved in lipid metabolism in mice models. These 
microarray experiments have further confirmed the role of ro-3 PUF A in the regulation of 
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genes involved in fatty acid synthesis, desaturation, transport and oxidation (Berger et al., 
2002; Lapillonne et al. , 2004). Evidently, co-3 PUFA play a major role in the regulation 
of gene expression in lipid metabolism. 
1.2.3 Regulation of transcription factors and nuclear receptors by fish oil 
co-3 PUF A mediated changes in gene expression were previously attributed to 
alterations in signaling by eicosanoid metabolites. However, the rapid and sustained 
changes in gene expression by co-3 PUF A were more consistent with a ligand mediated 
event, such as a PUF A binding transcription factor (Clarke 2000). The key transcription 
factors and nuclear receptors studied in response to co-3 PUFA mediated regulation are: 
1) Sterol-Regulatory Element Binding Proteins, 2) Peroxisome Proliferator-Activated 
Receptors and 3) Liver X-Receptors 
1.2.3.1 Sterol-Regulatory Element Binding Proteins (SREBP): SREBPs are helix-loop-
helix transcription factors which regulate lipid levels by binding to the sterol regulatory 
elements in promoters of genes involved in lipogenesis and cholesterol metabolism 
(Sam path and Ntambi 2005). There are three known isoforms of SREBP i.e. SREBP-1 a, 
SREBP-1c and SREBP-2. While SREBP-1c preferentially activates lipogenesis, SREBP-
2 preferentially enhances the transcription of genes involved in cholesterogenesis (Le 
Jossic-Corcos et al. , 2005). SREBPs play an important role in the co-3 PUF A induced 
suppression of lipogenic enzymes e.g. FAS, stearoyl CoA desaturase-1 (SCD1) and S14 
(Jump et al. , 1994; Xu et al., 1999b; Kim et al. , 1999; Y ahagi et al., 1999). DHA has 
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been shown to regulate nuclear SREBP-1 abundance in rat hepatocytes (Botolin et al. , 
2006). Regulation of SREBP-1 proteolytic degradation by ro-3 PUF A is considered to be 
the main mechanism controlling SREBP nuclear abundance. PUF A have also been shown 
to lower intracellular levels of SREBP-1c mRNA [Xu et al. , 1999b; Kim et al. , 1999; 
Y ahagi et al. , 1999]. This inhibition is dependent on chain length and degree of 
unsaturation, with EPA and DHA being more potent inhibitors than linoleic or oleic acids 
(Sam path and Ntambi 2005). While PUF A mediated regulation of SREBP-1 c mRNA 
levels involves an enhanced rate of SREBP-1 c mRNA turnover rather than inhibition of 
gene transcription in primary hepatocytes, several reports have demonstrated inhibition at 
the transcriptional level (Jump et al. , 2002; Ou et al. , 2001 ; Hannah et al. , 2001 ; Sealls et 
al. , 2008). 
1.2.3 .2 Peroxisome Proliferator-Activated Receptors CPP ARs): Three isoforms of PP AR, 
PP AR -a, -~/8, - y have been identified. The isoform PP ARa is predominant in the liver 
and regulates genes involved in lipid transport and oxidation. On the other hand, PP ARy 
is expressed in muscle and adipose tissue and aids in adipocyte differentiation. All PP AR 
isoforms bind EPA with Kd ranging from 1-4 )lM (Jump 2002). EPA is reported to bind 
to PP AR in two conformations. In the first conformation, EPA gets completely buried in 
the binding pocket and alters the conformation to stabilize the activator function 2 helix. 
This stabilization allows for coactivator recruitment and subsequent PP AR mediated gene 
expression. Second conformation reveals that fatty acid hydrophobic tail stays exposed to 
the solvent. Since fatty acids <14 carbons or >20 carbons cannot fit in the docking site 
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and stay exposed to solvent, thereby hindering helix stabilization, 18 carbon (oleic acid) 
and 20 carbon (EPA) fatty acids appear to be optimal for PP AR activation (Xu et al., 
1999a). Next, though PP ARa binds EPA and oleic acid with similar affinity, EPA but not 
oleic acid activates PP ARa in primary rat hepatocytes (Xu et al. , 1999a; Ren et al. , 
1997). This physiological discrimination is explained by the fact that compared to EPA, 
oleic acid is the preferred substrate for diacylglycerol acyl transferase in triglyceride 
synthesis. Reduced metabolism of EPA results in elevated cellular levels of EPA needed 
for PP AR activation. EPA, but not DHA, has been shown to induce mRNA expression of 
PP ARy (Chambrier et al. , 2002). Structural analysis showed that EPA is an endogenous 
ligand for PP ARs and DHA needs to be converted to EPA to activate PP ARs (Xu et al. , 
1999a; Sprecher 2000). Moreover, eicosanoid metabolites of PUF A are more potent 
activators of PP ARs than their fatty acid precursors (Sam path and Ntambi 2005). Genetic 
polymorphisms in PP ARy2 have been associated with the inter-individual variability in 
serum TG response to co-3 PUF A (Lindi et al., 2003). Some recent reports have shown 
agonist-driven PPARa activation to induce hepatic FAT/CD36 expression (Bonen et al., 
2004) and hepatic LPL mRNA as well as LPL activity (Auwerx et al. , 1996). These 
findings emphasize a need for a better understanding of the regulation of PP ARs by co-3 
fatty acids in vivo. 
1.2.3.3 Liver X Receptors (LXRs): LXRa and LXR~ regulate the expression of several 
genes involved in lipid metabolism, e.g. cholesterol ?a-hydroxylase (Cyp7a), LPL, F AS, 
ACC and SREBP-1 c (Sampath and Ntambi 2005). While fish oil enrichment of diet 
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resulted in the induction of PP ARs and repression of SREBP, dietary fish oil did not 
reveal any effect on classical LXR target genes such as Cyp7a and ABCG5 in HEK293 
cells (Pawar et a!., 2003). Previously, SREBP mediated repression of lipogenesis by 
PUF A was considered to be LXR dependent (Yoshikawa et a!. , 2002b ), however recent 
evidence suggests that the repression of SREBP-1 c mRNA levels by PUF A is 
independent of LXR. It was observed that treatment of HEK293 cells with EPA resulted 
in SREBP-1c mRNA inhibition both in the presence and absence of an LXR agonist 
(Pawar et al., 2003). However, to date there is no in vivo evidence for the regulation of 
LXR by ro-3 PUF A. 
1.3 Controversies associated with the beneficial health effects of fish oil 
A large systematic study on the effects of ro-3 PUF A on total mortality due to 
CVD suggested that the beneficial effects of ro-3 PUF A were not conclusive (Hooper et 
al., 2006). Recently, a meta-analysis of randomized controlled trials in patients at risk of 
ventricular arrhythmia showed enormous heterogeneity in patient response to fish oil 
supplementation (Jenkins et al. , 2008). Moreover, while the hypotriglyceridemic effects 
of fish oil are well established, the effects of fish oil on plasma total cholesterol and 
LDL- cholesterol are still controversial. While some studies show LDL-cholesterol 
reducing effects of fish oil feeding in normolipidemic patients, other studies report 
elevated plasma total- and LDL-cholesterol levels in response to fish oil in 
normolipidemic and hyperlipidemic individuals (Illingworth et a!., 1984; Neste! et a!. , 
1984; Sullivan eta!., 1986; Hsu et al., 2000; Harris, 1997; Rivellese et al., 2003). Pre-
11 
existing dyslipidemia, e.g. hypertriglyceridemia and Type II diabetes, are believed to 
cause greater elevations in plasma total- and LDL-cholesterol concentrations upon fish 
oil consumption (Farmer et al. , 2001 ). 
Dietary fish oil has also been reported to induce hyperlipidemia, which was more 
evident in animals fed fish oil and cholesterol (Kubow et al. , 1996; Lu et al. , 1996; Lin et 
al. , 1995). Addition of cholesterol (0.5% w/w) to fish oil diet primarily resulted in an 
increase in total plasma, VLDL- and LDL-cholesterol levels in Golden Syrian hamsters 
(Lin et al. , 1995). Interestingly, however, TG levels were reduced even further upon 
supplementation of fish oil diet with 0.5% w/w cholesterol. Dose dependent 
hypercholesterolemic effect of dietary cholesterol given with the fish oil diet was shown 
in the hamster model. Fish oil in Golden Syrian hamsters has been reported to increase 
the ApoB/ ApoA 1 ratio, which has been linked to an increased risk of atherosclerosis 
(Hayes et al., 1990). 
Previous studies from our laboratory have shown that BioF 1 B hamsters are highly 
susceptible to fish-oil induced hyperlipidemia at high fat levels (de Silva et al. , 2004). 
Another study from our laboratory compared the effects of fish oil feeding in Golden 
Syrian hamsters and BioF1B hamsters (Cheema and Cornish, 2007). High levels of fish 
oil feeding in BioF 1 B hamsters demonstrated dramatic hyperlipidemic response as 
compared to Golden Syrian hamsters. This study showed for the first time that alterations 
in LPL activity and mRNA expression levels play an important role in the varied 
response of these hamsters to dietary fats (Cheema and Cornish, 2007). These findings 
12 
highlight the significance of genetic background in the regulation of lipid and lipoprotein 
metabolism in response to fish oil. 
1.3.1 Dietary fish oil and oxidative stress 
Fish oil supplementation has been commonly associated with increased in vivo 
lipid peroxidation and compromised anti-oxidant status in organs, blood and urine of 
experimental animals and humans (Kaasgaard et al., 1992, Cho et al. , 1995; Ando et al. , 
1998; Ando et al. , 2000). High fish oil diet (19% (w/w) menhaden oil) markedly 
increases the oxidative potential in the mammary gland of spontaneously hypertensive 
rats (Mehta et al. , 1994). High dietary fish oil (20% (w/w) menhaden oil) has also been 
reported to increase the hepatic and faecal levels of oxidized lipids in male F344 rats 
(Dommels et al. , 2003). Yuan and Kitts (2003) reported the effect of high menhaden oil 
diet on lipid oxidation and anti-oxidant enzyme status in spontaneously hypertensive rats 
and Wistar Kyoto rats. Significantly elevated levels of lipid peroxidation in the hearts and 
livers of menhaden oil fed animals were attributed to alterations in anti-oxidant enzyme 
activities. Interestingly, addition of cholesterol (5g/kg diet) significantly lowered the 
hepatic reduced glutathione levels and exerted a protective effect against enhanced 
oxidative stress in these rats. It was concluded that high doses of ro-3 PUFA enhance the 
tissue susceptibility to oxidation, which can be modulated by supplementing dietary 
cholesterol in spontaneously hypertensive rats and Wistar Kyoto rats. Atalay et al. (2000) 
demonstrated increased activity of catalase, glutathione peroxidase and glutathione - S-
transferase in rats in response to fish oil and exhaustive exercise. Increased aortic lesions 
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and elevated plasma lipid peroxidation levels have been reported for rabbits fed fish oil 
(Thiery and Seidel, 1987). Additionally, fish oil supplementation induced oxidative stress 
resulted in an increased requirement for vitamin E (Atalay et al. , 2000). 
ro-3 PUF A in dietary fish oil can efficiently be incorporated into tissue membrane 
phospholipids by displacing the ro-6 PUF A. The increased unsaturation of membrane 
phospholipids due to incorporation of EPA and DHA from fish oil is thought to be the 
major cause of elevated in vivo lipid peroxidation since these membranes are likely to be 
more susceptible to oxidative stress (Leibovitz et a!., 1990). Fish oil induced lipid 
peroxidation has further been related to fish oil induced hyperlipidemia (Kubow, 1998). 
On the contrary, some investigators have reported protective effects of dietary fish 
oil against oxidative stress. Erdogan et al. , (2004) assessed the effect of fish oil 
supplementation on plasma thiobarbituric acid-reactive substances (TBARS), nitric 
oxide, xanthine oxidase, superoxide dismutase and glutathione peroxidase in rats. These 
authors concluded that ro-3 PUF A enhanced resistance to free radical attack and lowered 
lipid peroxidation. ApoE knockout mice fed fish oil showed increased anti-oxidant 
enzyme activities in macrophages and reduced atherosclerotic lesions compared to com 
oil fed animals (Wang et a!. , 2004). These findings further support the anti-oxidant 
effects of ro-3 PUFA in spontaneously hypertensive rats (Frenoux eta!. , 2001). Thus, 
fish oil supplementation may help restore the balance between anti-oxidant status and 
oxidative stress in the cell. Increased anti-oxidant enzyme activity can lead to increased 
free radical scavenging, thereby conferring enhanced resistance against free radical 
damage and delay the progression of atherosclerosis. 
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Interestingly, inverse correlation has been reported between the extent of lipid 
peroxidation and DNA damage in response to dietary fish oil. Kikugawa et al. (2003) 
suggested that dietary fish oil co-administered with vitamin E induced lipid peroxidation 
via increased levels of hydroperoxides and TBARS but lowered DNA damage in rat liver 
in vivo. DNA damaging potencies of the peroxidation products is proposed to be lower 
compared to that seen with ROS mediated oxidative stress. This explains how an increase 
in the extent of lipid peroxidation results in the attenuation of oxidative stress induced 
DNA damage, pointing to the protective effects of fish oil feeding. Consuming ro-3 
PUF A is also believed to confer resistance to CM remnants against free radical attack and 
thus attenuates their potential atherogenic properties (Napolitano et a!. , 2004). Fish oil 
supplementation has also been associated with reduced oxidative stress in 
hyperinsulinemic rats (Nyby et a!. , 2005). These contradictory results of fish oil feeding 
emphasize the need to study the regulation of fish oil induced oxidative stress under 
hyperlipidemic conditions. 
1.3.2. Combination of fish oil and vitamin E in the prevention of CVD 
ro-3 PUF A such as DHA has been reported to decrease vitamin E levels in plasma 
and tissues of several experimental animals (Farwer et al. , 1994; Kubo et a!., 1997; Surai 
and Sparks, 2000). Thus, fish oil induced lipid peroxidation can be correlated with 
reduced vitamin E levels. Elevated lipid peroxidation and low tocopherol concentrations 
have further been associated with increased tissue cholesterol concentrations 
(Chupukcharoen eta!. , 1985). Hence, an increase in oxidative stress may be a causative 
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factor in diet induced hyperlipidemia. Cho and Choi (1994) proposed that increasing 
vitamin E supplementation could be an effective strategy for preventing tissue 
peroxidation in co-3 PUF A supplemented subjects. Vitamin E has been shown to protect 
erythrocyte and liver microsome lipids rich in co-3 PUF A against lipid peroxidation 
during postnatal development of rats (Suarez' et al. , 1999). Vitamin E is believed to 
efficiently inhibit fatty acid peroxidation via its anti-oxidant effects. This further helps to 
enhance the incorporation of co-3 PUF A in different tissues, thereby lowering co-6/co-3 
ratio and improving the efficiency of dietary fish oil. High supplemental dosage of 
vitamin E has been shown to significantly enhance the hypotriglyceridemic effects of 
dietary fish oil in normolipidemic humans (Haglund eta!. , 1991 ). 
Kubow et a!. (1996) reported that supplementing dietary fish oil with vitamin E 
significantly reduced the extent of tissue lipid peroxidation and hyperlipidemia in Golden 
Syrian hamsters. Cosupplementation of vitamin E with fish oil markedly decreased fish 
oil induced antioxidant enzyme activities in the livers of rats after exhaustive exercise 
(Atalay et a!., 2000). These studies suggest that vitamin E supplementation can 
potentially confer protection against CVD either by regulating oxidative stress or lipid 
metabolism. However, the beneficial effects of combination of vitamin E and co-3 PUF A 
on CVD mortality in the randomized controlled GISSI trial were attributed to co-3 PUF A 
alone with no significant effects of vitamin E supplementation (Shekelle et a!. , 2004). 
Other independent randomized controlled trials to evaluate the effects of vitamin E on 
cardiovascular events/cardiovascular mortality have also revealed that anti-oxidant 
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vitamin E does not affect CVD either positively or negatively (Vivekananthan et al. , 
2003; Morris and Carson, 2003). 
O'Malley (2004) offered possible explanations for the failure of potential anti-
oxidant therapy in clinical outcomes. Firstly, anti-oxidant therapy might be more 
effective in retarding/inhibiting the progression of atherosclerosis if implemented at early 
stages of the disease. Anti-oxidant therapy in most randomized controlled trials is either 
aimed at secondary prevention in patients who had experienced myocardial infarction or 
primary prevention in older high-risk patients. Secondly, optimal anti-oxidant activity 
necessary to affect complex atherogenic processes might not be achieved in the form of 
supplemental pills due to limited absorption and bioavailability. These observations 
emphasize the need to investigate more biologically active antioxidants in future. 
1.4 Anthocyanins as biologically active anti-oxidants 
In an attempt to discover biologically active anti-oxidants, research has now 
focused on anthocyanins, due to their high anti-oxidant potential and abundance in fruits 
such as berries. Anthocyanins are water soluble, glycosylated and non-acetylated 
polyphenolic compounds which belong to the flavanoid class of compounds and impart 
red, blue and purple colour to various fruits and vegetables (Bell and Gochenaur, 2006; 
Clifford, 2000; Galvano et al. , 2004). While approximately 400 individual anthocyanins 
have been identified, six are most commonly found in colored fruits especially berries. 
These are classified on the basis of number and position of hydroxyl and methoxyl 
moieties on the flavan nucleus (Mazza, 2007). Cyanidin is believed to be the most 
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abundant anthocyanidin in nature. Free radical scavenging capacity of anthocyanins is 
reduced upon glycosylation due to reduced ability of the anthocyanin radical to delocalize 
electrons (Mazza, 2007). Thus, a comparison between the anti-oxidant potential of 
different anthocyanidin molecules revealed direct proportionality to the number of 
hydroxyl groups and inverse proportionality to the number of glycosyl groups (Fukomoto 
and Mazza, 2000). Anthocyanins possess a wide spectrum of therapeutic properties such 
as anti-oxidant, hypolipidemic, anti-inflammatory and anti-thrombotic effects (Wang et 
a!. , 1997; Fukumoto and Mazza, 2000; Mazza et a!. , 2002; Wang and Mazza, 2002; 
Morazzoni and Magistretti, 1990; Satue-Gracia eta!. , 1997). 
1.4.1 Anti-oxidant potential of anthocyanins 
Anthocyanins are potent anti-oxidants and reactive oxygen species scavengers 
and thus can be beneficial in reducing oxidative stress associated with CVD. Dietary 
flavanoids have been demonstrated to significantly reduce the amounts of dienes 
produced during 12 hours of oxidation in PUFA rich diet fed rats (Fre'mont L eta!. , 
1998) and lengthened the lag time in rats fed monounsaturated fatty acids (MUF A). 
These flavanoids can potentially protect circulating and membrane lipids by sparing 
vitamin E and endogenous antioxidants. Proanthocyanidin administered rats showed 
increased resistance against copper-ion induced oxidation of blood plasma (Koga eta!. , 
1999). Proanthocyanidin rich extracts can trap reactive oxygen species in plasma and 
interstitial fluid of the arterial wall, thereby inhibiting LDL oxidation and potentially 
preventing the progression of atherosclerosis. Dietary supplementation with grape seed 
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proanthocyanidins lowered the postprandial oxidative stress by decreasing the oxidant 
and increasing the anti-oxidant levels in the plasma of healthy human volunteers (Natella 
et al. , 2002). Proanthocyanidin rich grape seed extract also resulted in improved 
resistance to oxidative modification of LDL by reducing plasma lipid hydroperoxides and 
the oxidant/ antioxidant status. Grape seed proanthocyanidins significantly inhibited the 
progression of atherosclerosis in the aorta of cholesterol fed rabbits (Yamakoshi et al., 
1999). 
Analysis of anthocyanins to detect radical scavenging activity present in different 
berries showed potent antiradical activities in all berry extracts (Nakajima et al. , 2004). 
Interestingly, anthocyanins have significantly higher anti-oxidant potential compared to 
classical anti-oxidants such as butylated hydroxyanisole, butylated hydroxytoluene and 
vitamin E and vitamin C (Wang et al., 1997; Fukumoto and Mazza, 2000). In vitro 
inhibition of enzymatic and non-enzymatic PUF A-mediated peroxidation occurred in a 
dose dependent manner by purified anthocyanins (Narayan et al. , 1999). Many studies 
report inhibition of LDL oxidation in vitro, further attesting to the anti-oxidant activity of 
anthocyanins (Teissedre et al. , 1996; Aviram and Fuhrman, 2002). Cyanidin-3-0-beta-
glucopyranoside, an anthocyanin, is known to significantly inhibit malondialdehyde 
generation in a dose dependent manner, with the extent of inhibition being significantly 
higher than those obtained with similar concentrations of resveratrol and ascorbic acid 
(Amorini et al. , 200 I). Fruits and vegetables rich in anthocyanins showed concentration 
dependent anti-oxidant activities in the inhibition of copper-induced liposome 
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peroxidation as well as in inhibiting co-oxidation of linoleic acid and beta-carotene 
(Hassirnotto et al. , 2005). 
Ramirez-Tortosa et al. (200 1) reported that dietary anthocyanins significantly 
improved plasma anti-oxidant capacity and lowered the vitamin E deficiency-enhanced 
hydroperoxides and 8-oxo-deoxyguanosine concentrations in rat livers. Anthocyanins 
from chokeberry significantly reduced the levels of TBARS and thiol protein groups and 
improved the overall anti-oxidant status in Wistar rats (Kowalczyk et al. , 2002). A study 
on male subjects consuming freeze dried blueberries reported that the serum 
anthocyanins concentration correlated positively with the serum anti-oxidant capacity 
(Mazza et al., 2002). Elderberry anthocyanins are efficiently incorporated into the plasma 
membrane and cytosol of vascular endothelial cells (Youdim et al. , 2000). This 
enrichment of endothelial cells is proposed to confer significant protection against 
oxidative insult. Bagchi et al. (2004) evaluated several combinations of berry extracts and 
developed a synergistic formula OptiBerry IH 141 , which exhibited higher anti-oxidant 
and anti-angiogenic potential compared to other combinations studied. 
Anthocyanin doses of 40 mg/kg improved the total anti-oxidant capacity with 
increased superoxide dismutase activity and reduced serum malondialdehyde levels in 
models of Freund' s adjuvant induced arthritis (He et al., 2006). Han et al. (2006) reported 
antioxidant capacities of pigmented fractions from purple potato flakes in vitro due to 
increased radical scavenging activity and inhibition of linoleic acid oxidation. Authors 
further studied the anti-oxidant potential of anthocyanin-rich purple potato flake diet in 
rats. In comparison to the rats fed cornstarch rich diet, rats on purple potato flake diet had 
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significantly lower hepatic lipid peroxidation and elevated hepatic Cu/ Zn- and Mn-
superoxide dismutase and glutathione peroxidase mRNA expression and thus, improved 
anti-oxidant potential. Thus, anthocyanins can potentially exert anti-oxidant effects by 
regulating the genes involved in oxidative stress. These interesting findings emphasize 
the need to elucidate the efficacy of anthocyanins against oxidative stress in vivo and to 
establish whether anthocyanin supplementation could be a better alternative to vitamin E 
supplementation. 
1.4.2 Anti-atherogenic potential of anthocyanins 
Recently, some studies have reported that anthocyanins appear to play a major 
role in regulating various pathways involved in the development or progression of heart 
disease. Valcheva et a/. (2007a) reported significant hypoglycemic and hypolipidemic 
effects of anthocyanin-rich aronia melanocarpa fruit juice (1 0 and 20mL/kg body weight) 
in streptozotocin-induced diabetic rats. Fruit juice rich in anthocyanins significantly 
reduced plasma glucose and TG to levels comparable to normal rats and also 
counteracted the influence of streptozotocin on total cholesterol, LDL-cholesterol and 
high-density lipoprotein- (HDL) cholesterol. These authors also showed 
antihyperlipidemic effects of anthocyanin-rich aronia melanocarpa fruit juice in rats with 
dietary induced hyperlipidemia (Valcheva et al. , 2007b). Anthocyanin-rich juice 
significantly hindered elevations in plasma total cholesterol, LDL-cholesterol and TG 
levels seen in rats fed high cholesterol in the diet. Lyophilized grape powder 
supplementation, a rich source of flavans such as anthocyanins, significantly reduced 
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plasma TG, LDL-cholesterol, ApoB, ApoE levels as well as cholesterol ester transfer 
protein (CETP) activity in both pre-and post-menopausal women (Zem et al. , 2005). 
While LDL oxidation was not affected upon supplementation, whole-body oxidative 
stress assessed by urinary-F2-isoprostanes was significantly reduced in these subjects. In 
another study, rats fed a combination of high fat diet and black soybean anthocyanins had 
significantly lower serum TG and cholesterol levels and markedly elevated HDL-
cholesterol concentrations as compared to animals fed high fat diet alone (Kwon et a!. , 
2007). A randomized, placebo controlled trial studied the effects of elderberry juice 
(containing 10% anthocyanins) on serum lipids and anti-oxidant status in healthy 
volunteers (Murkovic et a!., 2004 ). While low dose treatment (equivalent to SmL 
juice/day for 2 weeks) did not reveal any significant differences in serum lipid levels and 
anti-oxidant status, higher, but nutritionally relevant doses (single dose equivalent of 50 
rnL juice) significantly lowered postprandial serum lipids. Thus this dosage was used as a 
reference standard for the current thesis investigation (details in methodology section). 
Furthermore, soybean anthocyanins have been proposed to possess anti-obesity 
effects which can potentially reverse the effects of high fat diets on body weight, adipose 
tissue weight and serum lipid profile (Kwon eta/., 2007). Other studies have also shown 
that anthocyanin supplementation can effectively suppress increases in body weight gain 
observed in response to high fat diet and may be beneficial in prevention and control of 
obesity (Tsuda et a!. , 2003; Jayaprakasam et a!., 2006). Polyphenol compounds might 
have anti-obesity effects in female Zucker fatty rats through inhibition of fat metabolizing 
enzymes (pancreatic lipase, adipose-tissue derived LPL and glycerphosphate 
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dehydrogenase activities) and enhanced lipolysis (Yoshikawa et al. , 2002a). 
Anthocyanins can also exert anti-atherogenic effects by modulating several inflammatory 
pathways. Berry extract anthocyanins have been shown to play an immuno-modulatory 
role by attenuating various parameters of inflammation such as nitric oxide synthesis, 
adhesion molecules and prostaglandins (Pergola et al. , 2006; Rossi et al. , 2003). 
Moreover, atherosclerotic plaque stability was shown to improve remarkably in 
ApoE -deficient mice upon dietary supplementation with an anthocyanins-rich extract 
from black rice (Xia et al. , 2006); extracts rich in anthocyanins dramatically improved 
serum lipid profile by lowering TG, total-cholesterol and non-HDL cholesterol levels. 
Lipid-lowering and anti-inflammatory properties of anthocyanins are thought to be 
primarily responsible for the beneficial effects of anthocyanins in ApoE deficient mice. 
On the contrary however, adverse effects of anthocyanin supplementation on plasma 
cholesterol and LDL- cholesterol levels were observed in Watanabe Heritable 
Hyperlipidemic rabbits fed purified anthocyanins (Finne-Nielsen IL et al. , 2005). Thus, 
therapeutics involving anthocyanins must be viewed with caution, particularly in patients 
with Familial Hypercholesterolemia (Frolov and Hui, 2007). More studies need to be 
done to evaluate the safety and efficacy of anthocyanins with regard to variability in 
genetic background of experimental models. 
1.5 Other marine source of ro-3 PUF A: Seal oil 
To date studies reporting health benefits of co-3 PUF A have primarily focused on 
increasing the consumption offish oil. These studies, however, have failed to consistently 
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achieve low levels of CVD upon fish oil supplementation as that observed in the Eskimo 
and Greenland Inuit populations. The inconsistencies could partly be due to the fact that 
the Greenland Eskimos also consumed other marine mammals such as seal and whale 
besides fish. Seal oil supplementation in healthy volunteers was found to significantly 
reduce plasma TG and ro-6/ro-3 ratio of plasma and erythrocytes without any significant 
effects on cholesterol levels (Bonefeld-Jorgensen et al. , 2001). Another study by Conquer 
et al. (1999) demonstrated that seal oil supplementation resulted in lower ro-6/ro-3 ratio 
and higher EPA, DHA and docosapentaenoic acid (DPA; 22:5) levels in healthy, 
normocholesterolernic subjects. They further showed that seal oil increased the ratio of 
EPA/arachidonic acid and DHA/arachidonic acid in the serum phospholipids and FF As. 
However, no significant differences were observed on glucose, plasma TG and 
cholesterol levels in response to seal oil consumption. 
There are some differences in the ro-3 PUF A composition of seal oil and fish oil. 
While EPA and DHA content of seal oil is slightly lower as compared to fish oil, DP A 
levels are approximately 3 fold higher in seal oil (Brox et al. , 2001 ). The two marine 
sources of ro-3 PUF A further differ in the intramolecular distribution of ro-3 PUF A on 
their TG molecules. While EPA and DHA are primarily distributed in the sn-1 and sn-3 
positions of seal oil TGs, they are located in the sn-2 position in case of fish oil TGs 
(Christensen et al. , 1994). Seal oil and fish oil fed guinea pigs showed significantly 
higher concentration of ro-3 PUF A in different organs and plasma as compared to com oil 
fed animals (Murphy et al. , 1999b ). Differences in the pattern of incorporation of ro-3 
PUF A were also noted for the two marine oils. While fish oil feeding resulted in higher 
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levels of EPA in plasma TG, dietary seal oil led to maximal incorporation of EPA in 
heart polar lipids. DHA levels were significantly higher in heart TG from fish oil fed 
guinea pigs compared to seal oil fed guinea pigs. In contrast, heart polar lipids had 
significantly higher levels of DP A in response to dietary seal oil compared to fish oil. 
Yoshida et a/. (1999) reported the effects of dietary seal and fish oils on TG 
metabolism in rats. Their findings showed that seal oil was more effective compared to 
fish oil in lowering serum and liver TG concentrations. Significantly lower activities of 
fatty acid synthase, glucose-6-phosphate dehydrogenase and hepatic TG lipase were 
observed in seal oil fed rats compared to those fed linoleic acid. In a similar study on 
hamsters, these authors also showed that dietary seal oil reduced arachidonic acid content 
m liver phosphatidylcholine and phosphatidylethanolamine, and serum 
phosphatidylcholine more effectively as compared to fish oil (Yoshida et al., 2001 ). 
Different intramolecular distribution of ro-3 PUF A in dietary fats is believed to 
regulate lipid metabolism differently in experimental animals. These structural 
differences can potentially influence the uptake and bioavailability of ro-3 PUF A due to 
the stereospecificity of pancreatic lipase and gastrointestinal lipase, both of which 
hydrolyze primary ester bonds of TG molecule. While ro-3 PUF A are mostly absorbed as 
sn-2 monoacylglycerols upon fish oil consumption, these are absorbed as FF As after 
consuming seal oil. This can potentially alter the digestion and absorption efficiency of 
different ro-3 PUF A (Christensen et al. , 1995). A comparison of the rate of CM clearance 
following either seal oil or fish oil injection showed a faster clearance of seal oil CM 
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compared to fish oil CM. This has been attributed to structural differences in 
intramolecular distribution of co-3 PUF A in TO of dietary fats (Christensen eta!., 1995). 
Another potential advantage of seal oil supplementation is enhanced resistance to 
oxidation compared to fish oil (Nakhla, 1997). While co-3 PUF A from fish oil are highly 
susceptible to oxidation resulting in the formation of lipid hydroperoxides, seal oil co-3 
PUF A are relatively resistant to oxidation. In light of these findings, there is a need to 
further investigate the role of seal oil in comparison with fish oil in the regulation of lipid 
metabolism and oxidative stress. 
1.6 Choice of hamster as an animal model 
The hamster is an animal model of choice to study lipoprotein metabolism and 
atherosclerosis because the lipoprotein profile of hamsters closely resembles that of 
humans (Nistor eta!., 1987; Spady and Dietschy, 1988). Hamsters carry a significant 
proportion of their circulating lipoprotein in LDL fraction, which is similar to humans 
(Ohtani eta!., 1990). Moreover, as opposed to rodents, hamsters possess plasma CETP 
activity similar to that in humans (Ahn et a!. , 1994; Ha and Barter, 1982). Hamsters also 
resemble humans in the secretion of TO-rich lipoproteins in that the origin of ApoB48 
and ApoB100 is intestinal and hepatic respectively, however in case ofrats and mice both 
the ApoB isoforms are secreted from liver. In the context of cholesterol metabolism, 
hamsters show hepatic cholesterol synthesis similar to that in humans (Spady and 
Dietschy 1988; Woollett et al. , 1989) and partial regulation of cholesterol metabolism by 
LDL receptors (Chen et a!., 1996; Remillard et al. , 2001). Dietary cholesterol and 
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saturated fat have been shown to result in greater serum LDL-cholesterol concentrations 
similar to that observed in humans (Sullivan et al., 1993). Moreover, genetic variability 
in hamster strains has been associated with differences in response to dietary fats 
(Dorfman et al. , 2003). 
BioF1B hamster, an inbred strain from Bio 87.2 and Bio 1.5 parent strains, is an 
established model for diet-induced hyperlipidemia and atherosclerosis. Kowala et al. 
(1991) reported that the BioF1 B strain of hamsters showed atherosclerotic lesions even at 
low concentrations of dietary cholesterol. Increased concentrations of TG-rich 
lipoproteins upon cholesterol supplementation have been associated with the increased 
susceptibility of BioF 1 B hamsters to hyperlipidemia and atherosclerosis (McAteer et al., 
2003). Dyslipidemic individuals (hypertriglyceridemic, diabetic) have been reported to 
show greater elevations in plasma total and LDL cholesterol levels (Hsu et al., 2000, 
Farmer et al., 2001), compared to normolipidemic subjects in response to dietary fish oil. 
Similar to hyperlipidemic humans, BioF1B hamsters fed an atherogenic diet showed 
increased total cholesterol/HDL levels and increased susceptibility to atherosclerosis 
(Trautwein et al. , 1993). Our lab has previously demonstrated that BioF1B hamsters are 
susceptible to fish oil induced hyperlipidemia at high fish oil levels, in contrast to GS 
hamsters fed similar levels of fish oil. These lipid profile changes further suggest that 
genetic variability might play an important role in determining the final outcome of co-3 
PUFA supplementation. More studies are needed to ascertain whether BioF1B hamsters 
are representative of differential effects (if any) of high fish oil diet in hyperlipidemic 
humans. However, the relevance of genetic variability in the regulation of lipid 
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metabolism upon fish oil feeding emphasizes the need for investigating lipid regulation in 
fish oil fed hyperlipidemic animal models and subsequently hyperlipidemic human 
populations. 
1. 7 Justification of the study 
Existing data suggests that differential responses to dietary treatments might arise 
due to heterogeneity in genetic background and gene-nutrient interactions in different 
experimental models (Katan eta/., 1986; Overturf et al., 1990). Previous studies from our 
laboratory to investigate the effects of high fish oil feeding i.e. 20% (w/w) vs 5% (w/w), 
on the regulation of lipoprotein metabolism have reported the occurrence of diet induced 
hyperlipidemia in genetically susceptible BioF1B hamsters (de Silva et a/. , 2004). 
Interestingly, BioFlB hamsters fed the high fish oil diet showed the presence of milky 
plasma rich in CM like particles after an overnight fast. High fish oil supplementation 
also resulted in elevated plasma TG and plasma-, VLDL- and LDL- cholesterol 
concentrations in BioF1B hamsters as compared to BioF1B hamsters fed a mixture of 
lard and safflower oil (1.5: 1 ). Dietary fish oil supplemented BioF1 B hamsters further 
showed reduced hepatic LDL-receptor mRNA expression and significantly lowered 
CETP activity (de Silva eta/. , 2005). Following these preliminary observations from our 
laboratory using BioFlB hamsters, another study was undertaken to compare the effects 
of different types of high fat diets (fish oil, MUF A and ro-6/ ro-3 ratio of 5: 1) in Golden 
Syrian hamsters and BioF1B hamsters (Cheema and Cornish 2007). Contrary to the 
observations with fish oil fed BioFlB hamsters, fish oil fed Golden Syrian hamsters did 
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not reveal any milky plasma after an overnight fast. BioF1B hamsters fed high fat fish oil 
diet showed significantly elevated lipid levels as compared to fish oil fed Golden Syrian 
hamsters, highlighting the importance of genetic heterogeneity in response to dietary fat. 
Moreover, among the three different dietary treatments in BioF1B hamsters, diet induced 
hyperlipidemia was specific only to high fat fish oil diet. Molecular analysis revealed that 
fish oil fed BioF 1 B hamsters had higher levels of ApoB48 and ApoB 100 as compared to 
other dietary treatments, suggesting a reduced clearance of TG-rich lipoproteins (Cheema 
and Cornish, 2007). BioFlB hamsters revealed significantly lower post-heparin LPL 
activity as compared to Golden Syrian hamsters. Fish oil supplementation further 
inhibited the LPL activity in BioF1B hamsters compared to MUFA and ro-6/ ro-3 fed 
BioF1B hamsters (Cheema and Cornish, 2007). 
In an attempt to investigate the extent of oxidative stress in Golden Syrian and 
BioFlB hamsters in response to high fat diets, we measured the levels of lipid 
peroxidation and anti-oxidant enzymes in the liver. We observed significantly higher 
lipid peroxidation in BioFlB hamsters as compared to Golden Syrian hamsters. Fish oil 
feeding in BioFlB hamsters resulted in a further increase in the extent of lipid 
peroxidation compared to MUFA and ro-6/ro-3 fed BioFlB hamsters (Dubey and 
Cheema, unpublished data). Fish oil fed BioFlB hamsters also showed compromised 
anti-oxidant enzyme status suggesting an oxidative potential of high dietary fish oil in 
genetically susceptible BioFlB hamsters. 
The ro-3 PUF A, such as EPA and DHA are primarily located in sn-2 position in 
fish oil TGs, while these are distributed in sn-1 and sn-3 positions on seal oil TGs. The 
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structural differences in location of co-3 PUF A in the fish oil and seal oil TGs are 
considered to be important in producing better clearance and uptake of lipids from seal 
oil as compared to fish oil. Since fish oil-induced hyperlipidemia in BioFlB hamsters 
was attributed to hindered clearance of TG-rich lipoproteins and lower post heparin LPL 
activity, the current study was designed to investigate whether seal oil, another rich 
source of co-3 PUF A, with different distribution of co-3 PUF A in TG molecule as 
compared to fish oil, will differentially regulate lipid metabolism in BioFlB hamsters. 
We hypothesized that BioFIB hamsters will be able to metabolize dietary seal oil better 
as compared to fish oil due to positional distribution of co-3 PUFA. Moreover, seal oil is 
believed to be relatively resistant to oxidation as compared to fish oil. It was further 
hypothesized that the extent of oxidative stress will be lower in seal oil fed BioF1B 
hamsters as compared to fish oil fed hamsters. Anthocyanins are potent anti-oxidants 
with higher anti-oxidant potential as compared to classical anti-oxidants such as Vitamin 
E and Vitamin C. It was further hypothesized that a combination of anthocyanins and 
fish oil diet will suppress diet-induced hyperlipidemia and oxidative stress as compared 
to fish oil diet alone. We treated BioFlB hamsters with high fat diets (20% fat w/w) 
containing either fish oil or seal oil alone, or a combination of high fat diets (fish oil and 
seal oil) containing anthocyanin-rich elderberry extract (25% w/w anthocyanin). 
Thus, the present study was undertaken with two key objectives: 
1. To evaluate the effects of dietary seal oil, an alternative source of co-3 PUFA, on 
the regulation of lipoprotein metabolism and oxidative stress in BioF 1 B hamsters. 
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2. To investigate the effects of combination of anthocyanin-rich elderberry extract 
and ro-3 PUF A (fish oil and seal oil) on lipid profile and oxidative stress in 
BioF 1 B hamsters. 
The findings will help us to understand whether seal oil differentially regulates lipid 
and lipoprotein metabolism in BioFlB hamsters, and whether combinational therapy with 
anthocyanin rich elderberry extract and marine oils will have a greater effect on lowering 
plasma lipids and oxidative stress as compared to marine oils alone. 
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Chapter 2: Methodology 
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2.1 Animals and diets 
Bio FIB hamsters (male, 7 weeks old) were obtained from Bio Breeders Inc 
(Water Town, MA). During the initial equilibration period, hamsters were kept on a chow 
diet for 1 week. Hamsters were then divided into 4 groups (n = 6) and kept on specified 
diets for 4 weeks. The specified diets consisted of custom-made fat-free semipurified diet 
(ICN Biomedical Inc., OH, USA) that was either supplemented with 20% (w/w) fish oil 
(FO) (Menhaden oil, Sigma- Aldrich, Ontario, Canada) or 20% (w/w) seal oil (SO) 
(Ocean Choice Ltd, NL, Canada). Within each high fat diet group, hamsters were either 
fed 20% (w/w) fat alone or were given a combination of 20% (w/w) fat and elderberry 
extract (40 glkg diet) (Murkovic et al., 2004). Elderberry (25% w/w anthocyanin), spray-
dried powder (Nutrican Nutritionals Ltd. ON, Canada) was mixed with fat and added to 
the diets. All the diets were stored at -20°C. The diet composition is given in Table 2.1 . 
Experimental design for different dietary treatments is given in Figure 2.1. 
The animals were housed in individual cages in a single room. The room 
conditions were maintained at 12-12hr light-dark cycles (room was lit from 07:00 to 
19:00 hrs), temperature kept at 23 ± 1 oc and humidity at 35 ± 5%. Fresh diets were given 
to the animals daily, and experimental diets and water were given ad libitum for 4 weeks. 
Food intake was measured daily and body weight was measured once a week. All 
experiments were approved by Memorial University's Institutional Animal Care 
Committee in accordance with the guidelines of the Canadian Council for Animal Care. 
At the end of 4 week feeding period, animals from each diet group were euthanized after 
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Table 2.1: Composition (g/kg) offish oil and seal oil di et. 
Components (g!kg) Fish Oil Diet • Seal Oil Diet • 
Casein 200 200 
DL-Methionine 3 3 
Sucrose 305 305 
Com Starch 190 190 
Vitamin Mix a 11 11 
AIN Mineral Mix a 40 40 
Fibre P 50 50 
Fat 200 200 
* Semi-purified diets were designed to obtain 200g!kg fat 
a Formulated to meet the national requirements (Natio nal Research Council, 1995) 
icals Inc., OH, USA) P Supplied as Alphacel non-nutritive bulk (ICN Biomed 
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Figure 2.1: Diagrammatic representation of the experimental design for different dietary 
treatments. 
Fish oil 
BioFlB hamsters 
(male, 8-week old, 20% (w/w) fat) 
Fish oil + Elderberry 
extract 
Seal oil 
I 4 weeks 
Overnight fast 
l 
Plasma and tissues stored at -80°C 
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Seal oil + Elderberry 
extract 
an overnight fast. Blood samples were obtained by cardiac puncture and collected in 
tubes containing EDTA, centrifuged immediately at 3000 rpm, 4°C for 15 min to separate 
plasma. Plasma samples were stored on ice at 4°C. Liver tissues were snap frozen in 
liquid nitrogen and stored at -80°C until further use. 
2.2 Gas liquid chromatography 
The fatty acid composition of the diets was analyzed by Gas Liquid 
chromatography (GLC) (Table 2.2). Lipids were extracted from diets with 2: 1 
chloroform: methanol using the method of Y okode et al. (1990). Trans-methylation of 
lipids was done by adding 2 mL of transmethylation reagent (94% methanol, 6% HCl 
with few crystals of hydroxyquinone) followed by incubation at 65°C for 2 hrs. Fatty-
acid methyl esters were then extracted into the organic, hexane layer by adding hexane (1 
mL) and deionised water (1 mL). The upper hexane layer was evaporated under nitrogen 
and the fatty acid methyl esters were dissolved in 20 I-LL of carbon disulfide. The fatty 
acid methyl esters were run on an Omegawax x 320 (30 mm*0.32 mm) column from 
Supelco (Sigma-Aldrich, ON, Canada) using a flame ionization detector (FlO) for 1 hr. 
The GLC parameters were set as follows: oven at 196°C, injector at 240°C and detector 
at 250°C. Fatty acids were identified by comparison of retention times with those of 
known standards (Sigma-Aldrich, ON, Canada). 
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Table 2.2: Fatty acid composition offish oil and seal oil diets using Gas Liquid 
Chromatography 
Fatty acids* Fish oil Seal oil 
14:0 11 6.5 
16:0 18 10.1 
16:1 ro-7 12.2 16.8 
18:0 3.1 1.4 
18:1 ro-9 8.9 22.9 
18:2 ro-6 1.9 1.8 
18:3 ro-3 1.5 0.6 
18:4 ro-3 3.5 ND 
20:1 ro-9 1.1 10.9 
20:4 ro-6 0.8 0.5 
20:5 ro-3 12.6 9 
22:5 ro-3 2.2 5.2 
22:6 ro-3 12.1 11.7 
ISFA 32.1 18 
IMUFA 22.2 50.6 
IPUFA 34.6 28.8 
I ro-3PUFA 31.9 26.5 
I ro-6PUFA 2.7 2.3 
ro-6/ ro-3 ratio 0.085 0.087 
• Fatty acids are shown as % of the total fatty acids and represent the average of duplicate 
values. 
ND- Not detected 
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2.3 Plasma lipoprotein fractionation and lipid analysis 
Plasma samples were allowed to sit overnight on ice at 4 °C and the top layer 
containing the CM fraction was removed after centrifugation at 10000 rpm for 15 min. 
Density gradient ultracentrifugation was done to isolate VLDL, LDL (LDL+IDL) and 
HDL fractions corresponding to specific densities of <1.006, 1.006-1.060 and > 1.060 
g/mL respectively (de Silva et al. , 2004 ). Sequential separation of different fractions was 
obtained by using solutions containing increasing amounts of NaCl (VLDL and LDL 
fraction), or NaBr (HDL fraction) to adjust the density of plasma. 
For VLDL separation, 0.5 mL of plasma was mixed with 0.5 mL NaCl (density: 
1.0063 g/mL). Samples were then centrifuged at 100,000 rpm at l6°C for 2.5 hrs with an 
acceleration of 5 and a deceleration of 7 using TL 1 00 fixed angle rotor (Beckman 
instruments Inc., CA). The top 0.5 mL (density <1.006) was then transferred carefully to 
a tube labeled VLDL and kept on ice at 4°C. To isolate LDL, the remaining 0.5 mL 
bottom layer was mixed with 0.5 rnL NaCl (density: 1.12 g/mL) and centrifuged under 
conditions similar to VLDL isolation. After centrifugation, 0.5 mL of upper layer (LDL 
fraction) was again removed carefully and kept on ice at 4°C. Finally, to separate HDL, 
0.5 rnL of NaBr (density: 1.36 g/mL) was mixed with the remaining sample and 
centrifuged for 3.5 hrs under similar conditions as above. After centrifugation, 0.5 mL of 
upper layer was removed and kept on ice at 4°C. Isolated lipoprotein fractions i.e. VLDL, 
LDL and HDL were stored on ice at 4°C for lipid analysis. 
Whole plasma and the individual lipoprotein fractions were assayed immediately 
for total TG (Kit# 236-60, Diagnostic Chemicals Ltd, PE, Canada), total cholesterol (Kit# 
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225-S7, Diagnostics Chemicals Ltd, PE, Canada) and free cholesterol (Kit# 274-471 09E, 
Free cholesterol Enzymatic Kit, Wako Chemicals, VA, USA). Cholesterol ester 
concentrations were determined by subtracting free cholesterol concentrations from total 
cholesterol concentrations. 
2.4 Liver lipid analysis 
Lipids were extracted from liver tissue by homogenizing liver m 
chloroform/methanol (2: 1) (Folch eta/. , 1957). The lower organic phase was dried under 
nitrogen, and resuspended in 100 ~L of isopropanol. Hepatic lipids were analyzed for 
total cholesterol (Kit# 225-S7, Diagnostic Chemicals Ltd, PE, Canada), total TG (Kit# 
236-60, Diagnostic Chemicals Ltd, PE, Canada) and free cholesterol (Kit# 274-471 09E, 
Free cholesterol Enzymatic Kit, Wako Chemicals, VA, USA). Cholesterol ester 
concentrations were determined by subtracting free cholesterol concentrations from total 
cholesterol concentrations. Standards were also suspended in isopropanol for consistency. 
2.5 Plasma thiobarbituric acid reactive substances (TBARS) assay 
Plasma TBARS were assayed using the method of Ohkawa et al. (1979). The 
standards were prepared with 0.1mM 1,1,3,3 tetramethoxy propane (TMP) solution in 
absolute ethanol and 29 mmol/L thiobarbituric acid (TBA) solution was prepared in 
8.75M acetic acid. The following were added to 75 ~L of plasma or TMP standards: 100 
~L of 0.9% sodium chloride, 100 ~L of 15% trichloroacetic acid (TCA), 100 ~L of 
2.5mM butylated hydroxytoluene (BHT), 150 ~L of TBA and 60 ~L of 8.1% sodium 
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dodecyl sulfate (SDS). Tubes were then vortexed for 15 sec and kept in a water bath at 
95°C for 60 min. The samples were cooled on ice for 10 min and 750 IlL of n-butanol 
was added to all the tubes. This was followed by centrifugation at 4400 rpm (4°C) for 20 
min and the absorbance of the supernatant was read at 532 nm. TBARS concentration in 
the blood plasma was expressed as nmol MDAI!lL plasma from the standard curve. 
2.6 Liver TBARS assay 
The protocol for liver TBARS was similar to plasma TBARS with mmor 
modifications (Williamson et al. , 2003). TMP standards were prepared as described 
earlier for plasma TBARS assay. Approximately 100 mg of liver tissue was homogenized 
in 1 mL PBS and 300 IlL of the sample or standard was transferred to eppendorf tubes. 
This was followed by adding 150 IlL of 15% TCA, 150 IlL of 0.25 N Hydrochloric acid 
(HCl), 150 IlL of2.5mM BHT, 150 IlL of0.375% TBA and 60 IlL of8.1% SDS to each 
tube. Tubes were then vortexed for 15 sec and kept in a water bath at 95°C for 60 min. 
All samples were cooled on ice and centrifuged at 4400 rpm ( 4 °C) for 20 min. The 
supernatant was filtered through 0.45 llm syringe filters and the absorbance of the filtrate 
was measured at 532 nm. TBARS concentration in the tissue samples was expressed as 
nmol MDA/mg tissue from the standard curve. 
2.7 RNA isolation and reverse transcriptase PCR (RT-PCR) analysis 
Total RNA from hamster livers was extracted using TRIZOL reagent (Invitrogen 
Life Technologies Inc., Gaithersburg, MD, USA) and Fast Prep (BiolOl , ThermoSavant) 
40 
instrument. The yield of RNA samples was assessed by measuring the absorbance at 260 
nm and 280 nm. The integrity of RNA samples was verified by running the samples on 
1.2% agarose gels at 50V. Isolated RNA samples were stored at - 20°C until further 
analysis. 
RT-PCR was done to analyze the hepatic mRNA expressiOn of varwus 
transcription factors of BioF1B hamsters fed different diets. Isolated RNA samples were 
treated with RNase free DNase I (Promega) to remove any genomic DNA. Briefly, 4 J...Lg 
RNA sample was treated with 4 J...LL DNase (1 J...Lg/J...LL) and 1 J...LL DNase buffer (lOX). The 
final volume was made up to 10 J...LL with DEPC water. The samples were incubated at 
37°C for 30 min and reaction was terminated by adding 2 J...LL DNase stop solution. The 
samples were then incubated at 70°C for 10 min to inactivate DNase. 
Complementary DNA (eDNA) was synthesized by reverse transcription from 
DNase treated total RNA using AMV reverse transcriptase (Roche, QC, Canada) and 
used as template for PCR amplification. Briefly, DNase treated RNA (5 J...LL), IX random 
primers (1 J...LL) and 5 J...LL DEPC water were mixed and incubated at 70°C for 10 min. The 
samples were cooled on ice and centrifuged briefly. This was followed by addition of 8 
J...LL reaction mixture (4 J...LL of 5X RT buffer, 1 J...LL RNase inhibitor, 2 J...LL of 10 mM 
dNTPs and 1 J...LL DEPC water). Finally 1 J...LL of reverse transcriptase was added to each 
tube (except negative control) and incubated at 42°C for 1 hr. The eDNA template was 
stored at -20°C until PCR analysis. 
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PCR reactions were performed in the Genius PCR machine (Roche, QC, Canada) 
using the eDNA templates. PCR conditions were as follows: initial denaturation at 95°C 
for 10 min and then amplification cycles (denaturation at 95°C for 1 min, annealing for 2 
min and elongation at 72°C for 2 min). This was followed by a final elongation step of 10 
min at 72°C. The total number of cycles was chosen to remain within the exponential 
phase of the reaction. The specific primers used for SREBP-1 c (Shimomura eta!. , 1997), 
SREBP-2 (Field eta!. , 2003), PPAR-a (Valeille eta!. , 2005) and LXR-a (Valeille et al. , 
2005) and their specific annealing temperatures are given in Table 2.3. Different genes 
were amplified simultaneously with hamster P-actin pnmers (sense 5' -
CATCGTACTCCTGCTTGCTG-3 ' and antisense 5' -GCTACAGCTTCACCACCACA-
3 ' ) in a multiplex PCR. Figure 2.2 - Figure 2.4 depict the PCR amplification of SREBP-
lc, PPAR-a and LXR-a genes respectively. The mRNA expression of these genes was 
normalized to P-actin mRNA content and expressed as relative units. 
2.8 Statistical analysis 
Statistical analysis was performed using GraphPad Prism Software (GraphPad 
Software Inc., CA, USA). Differences between high fat diets were assessed using 
unpaired t-test and the effects of fat type and elderberry extract supplementation were 
analyzed using 2-way ANOV A. Newman-Keuls post-hoc test was used to test significant 
differences obtained by ANOVA analysis. Results are expressed as group means (n = 6) 
and ± SEM (standard error of mean). Differences were considered statistically significant 
at p-value ~ 0.05. 
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Table 2.3: Primer sequences and annealing temperatures for different genes studied. 
Gene Primer Sequence PCR Temp 
(bp) (oC) 
PPAR-a Sense: 5' -GAGAAAGCAAAACTGAAAGCAGAGA-3 ' 179 62 
Antisense: 5 ' -GAAGGGCGGGTTATTGCTG-3 ' 
LXR-a Sense: 5'-GCAACTCAATGATGCCGAGTT-3 ' 171 62 
Antisense: 5 ' -CGTGGGAACATCAGTCGGTC-3 ' 
SREBP-1c Sense: 5'-GCGGACGCAGTCTGGG-3 ' 95 60 
Antisense: 5' -ATGAGCTGGAGCATGTCTTCAAA-3' 
SREBP-2 Sense: 5'-AGCTGGCAAATCAGAAAAACAAG-3 ' 93 56 
Antisense: 
5 ' -GATT AAAGTCTTCAA TCTTCAAGTCCAC-3' 
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Hamster P-actin 
501 bp 
Hamster SREBP-1c 
95 bp 
1 2 3 
Figure 2.2: RT-PCR of SREBP-lc and P-actio. Hepatic mRNA from high fat fed 
BioF1B hamsters was reverse transcribed and multiplex PCR was performed to 
simultaneously amplify SREBP-1c and P-actin (described under the methods section). 
Lane1 depicts amplification in the absence of reverse transcriptase, lane2 shows the 
amplification of SREBP-1 c and P-actin in the presence of reverse transcriptase and lane3 
shows the 1 OObp ladder (molecular marker). 
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Hamster P-actin 
501 bp 
Hamster PP AR -a 
179 bp 
1 2 3 
Figure 2.3: RT-PCR ofPPAR-a and P-actio. Hepatic mRNA from high fat fed BioF1B 
hamsters was reverse transcribed and multiplex PCR was performed to simultaneously 
amplify PPAR-a and P-actin (described under the methods section). Lane1 depicts 
amplification in the absence of reverse transcriptase, lane 2 shows the amplification of 
PPAR-a and P-actin in the presence of reverse transcriptase and lane 3 shows the 1 OObp 
ladder (molecular marker). 
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Hamster P-actin __. 
501 bp 
Hamster LXR-a --. 
171 bp 
1 2 3 
Figure 2.4: RT-PCR ofLXR-a and P-actio. Hepatic mRNA from high fat fed BioF1B 
hamsters was reverse transcribed and multiplex PCR was performed to simultaneously 
amplify LXR-a and P-actin (described under the methods section). Lane1 depicts 
amplification in the absence of reverse transcriptase, lane 2 shows the amplification of 
LXR-a and P-actin in the presence of reverse transcriptase and lane 3 shows the 1 OObp 
ladder (molecular marker). 
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Chapter-3: Results 
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3.1 Effect of fish oil and seal oil 
3.1.1 Body weight and diet consumption 
At the end of 4-week dietary treatment, body weight gain (g) for BioFlB hamsters 
fed either fish oil (19.18±3.58) or seal oil (17.07±3.68) did not reveal significant 
differences. The average daily food consumption (g/day) of fish oil fed hamsters was also 
not significantly different as compared to hamsters fed seal oil (5.41 ± 0.21 and 6.05 
± 0.56 respectively). 
3.1.2 Plasma and lipoprotein lipid profile 
Plasma samples from BioF 1 B hamsters fed fish oil showed milkiness due to the 
presence of CM like particles. Milky plasma was however, not seen in seal oil fed 
BioF 1 B hamsters (Figure 3.1 ). 
TG concentrations in whole plasma and different lipoprotein fractions in fish oil and seal 
oil fed BioF1B hamsters are given in Figure 3.2 and Figure 3.3 respectively. Whole 
plasma TG concentrations in fish oil fed hamsters were significantly higher compared to 
seal oil fed hamsters (p< 0.0001). Significantly higher levels of TG were also noted in 
different lipoprotein fractions from fish oil fed hamsters compared to seal oil fed 
hamsters (p< 0.0001 for VLDL and LDL; p= 0.002 for HDL fractions). BioFIB hamsters 
fed fish oil also showed significantly higher whole plasma total cholesterol levels (p< 
0.0001) as compared to the seal oil fed animals (Figure 3.4). Analysis of different 
lipoprotein fractions for total cholesterol concentration showed a similar pattern where 
fish oil fed BioF 1 B hamsters revealed significantly higher concentrations of total 
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Fish Oil Seal Oil 
Figure 3.1: Fish oil fed BioFlB hamsters showed milky plasma containing chylomicron 
like particles. BioFl B hamsters were fed 20% (w/w) fish oil or 20% (w/w) seal oil diets 
for 4 weeks as described under the methods section. Blood was collected after 14 hours 
of fasting and plasma was separated. 
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Figure 3.2 Whole plasma triglyceride concentrations of BioFlB hamsters fed either fish 
oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma samples were 
assayed for triglycerides as described in the methods section. Values given are means ± 
SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
50 
20 
-
a 
-r--
-..J 15 :::: -
0 
E 
E 
-tn 10 Q) 
'C 
a 
- T 
·~ 
Q) 
0 a 
~ 
C) 5 
·~ 
1-
-
T 
b 
b b 
0 
VLDL LDL HDL 
Figure 3.3 Triglyceride concentrations in lipoprotein fractions of BioFlB hamsters fed 
either fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma samples 
were collected; lipoprotein fractions were separated by density gradient centrifugation 
and assayed for triglycerides as described in the methods section. Values given are means 
± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.4 Whole plasma total cholesterol concentrations of BioFlB hamsters fed either 
fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma samples were 
assayed for total cholesterol as described in the methods section. Values given are means 
± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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cholesterol (p< 0.0001 for VLDL and LDL; p= 0.005 for HDL) as compared to seal oil 
fed animals (Figure 3.5). 
Plasma cholesterol esters and free cholesterol concentrations in fish oil and seal 
oil fed BioF 1 B hamsters also followed a similar trend as the TG and total cholesterol 
concentrations. Whole plasma from fish oil fed BioF1B hamsters showed significantly 
higher levels of cholesterol esters (p< 0.0001) and free cholesterol (p= 0.0002) compared 
to seal oil fed hamsters (Figure 3.6 and Figure 3.8 respectively). Moreover, 
concentrations of cholesterol esters (p< 0.0001 for VLDL and LDL; p= 0.005 for HDL) 
(Figure 3.7) and free cholesterol (p= 0.0003 for VLDL; p< 0.001 for LDL; p= 0.003 for 
HDL) (Figure 3.9) were significantly higher in different lipoprotein fractions from fish 
oil fed BioF 1 B hamsters. 
3.1.3 Hepatic lipids of hamsters fed fish oil and seal oil 
Hepatic TG concentrations are shown in Figure 3.1 0. Fish oil feeding resulted in 
significantly higher TG concentrations as compared to seal oil feeding (p= 0.004). 
Hepatic total cholesterol, cholesterol esters and free cholesterol concentrations were also 
significantly different in response to different type of fat in the hamster diet (Figure 3.11 
- Figure 3.13). For all three lipid parameters, fish oil fed BioF1B hamsters had 
significantly higher concentrations (p< 0.0001) for total cholesterol (Figure 3.11 ), 
cholesterol esters (Figure 3.12) and free cholesterol (Figure 3.13). While hepatic total 
cholesterol and cholesterol ester concentrations were about 50% higher in fish oil fed 
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Figure 3.5 Total cholesterol concentrations in lipoprotein fractions of BioFlB hamsters 
fed either fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma 
samples were collected; lipoprotein fractions were separated by density gradient 
centrifugation and assayed for total cholesterol as described in the methods section. 
Values given are means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown 
with different letters depict statistically significant differences (p< 0.05). 
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Figure 3.6 Whole plasma cholesterol ester concentrations of BioFIB hamsters fed either 
fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma samples were 
assayed for cholesterol esters as described in the methods section. Values given are 
means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different 
letters depict statistically significant differences (p< 0.05). 
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Figure 3.7 Cholesterol ester concentrations in lipoprotein fractions of BioFIB hamsters 
fed either fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma 
samples were collected; lipoprotein fractions were separated by density gradient 
centrifugation and assayed for cholesterol esters as described in the methods section. 
Values given are means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown 
with different letters depict statistically significant differences (p< 0.05). 
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Figure 3.8 Whole plasma free cholesterol concentrations of BioFIB hamsters fed either 
fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma samples were 
assayed for free cholesterol as described in the methods section. Values given are means 
± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.9 Free cholesterol concentrations in lipoprotein fractions of BioFlB hamsters 
fed either fish oil (open) or seal oil (shaded) for a period of 4 weeks. Fasting plasma 
samples were collected; lipoprotein fractions were separated by density gradient 
centrifugation and assayed for free cholesterol as described in the methods section. 
Values given are means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown 
with different letters depict statistically significant differences (p< 0.05). 
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Figure 3.10: Hepatic triglyceride concentrations of BioFlB hamsters fed either fish oil 
(open) or seal oil (shaded), for a period of 4 weeks. Liver lipids were isolated and assayed 
for triglycerides as described in the methods section. Values given are means ± SEM 
(n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.11: Hepatic total cholesterol concentrations of BioFlB hamsters fed either fish 
oil (open) or seal oil (shaded), for a period of 4 weeks. Liver lipids were isolated and 
assayed for total cholesterol as described in the methods section. Values given are means 
± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.12: Hepatic cholesterol ester concentrations of BioFlB hamsters fed either fish 
oil (open) or seal oil (shaded), for a period of 4 weeks. Liver lipids were isolated and 
assayed for cholesterol esters as described in the methods section. Values given are 
means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different 
letters depict statistically significant differences (p< 0.05). 
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Figure 3.13: Hepatic free cholesterol concentrations of BioFlB hamsters fed either fish 
oil (open) or seal oil (shaded), for a period of 4 weeks. Liver lipids were isolated and 
assayed for free cholesterol as described in the methods section. Values given are means 
± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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hamsters compared to hamsters on seal oil diet, relatively smaller differences (25%) were 
observed for liver TG and liver free cholesterol. 
3.1.4 Hepatic mRNA expression of various transcription factors 
The hepatic mRNA expression of SREBP-1c, SREBP-2, PPAR-a, and LXR-a 
was measured from hamsters fed fish oil and seal oil diets. SREBP-1 c mRNA expression 
was significantly elevated in fish oil fed hamsters (p= 0.04) compared to seal oil fed 
hamsters (Figure 3.14). Expression levels ofSREBP-2 mRNA showed a trend towards an 
increase in fish oil fed hamsters compared to seal oil fed hamsters, however, this was not 
statistically significant (p= 0.08) (Figure 3 .15). There was no significant effect of fish oil 
or seal oil on the mRNA levels ofPPAR-a and LXR-a (Figure 3.16 and Figure 3.17 
respectively). 
3.1.5 Plasma and liver TBARS of BioFlB hamsters 
The extent of lipid peroxidation in fish oil and seal oil fed hamsters was evaluated 
using TBARS assay. Hamsters fed fish oil showed significantly higher levels of plasma 
lipid peroxides (p< 0.001) compared to seal oil fed hamsters (Figure 3 .18). Liver TBARS 
also showed significant effect of diet (Figure 3 .19), where fish oil fed hamsters had 
significantly elevated levels of liver TBARS compared to seal oil fed hamsters (p< 0.01 ). 
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Figure 3.14: Hepatic SREBP-lc mRNA expression of BioFlB hamsters fed either fish 
oil (open) or seal oil (shaded), for a period of 4 weeks. Total liver RNA was extracted, 
reverse transcribed and the eDNA template for SREBP-lc and ~-actin was amplified as 
described in the methods section. SREBP-lc mRNA expression was normalized against 
~-actin mRNA expression and expressed as relative units. Values given are means ± 
SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.15: Hepatic SREBP-2 mRNA expression of BioFlB hamsters fed either fish oil 
(open) or seal oil (shaded), for a period of 4 weeks. Total liver RNA was extracted, 
reverse transcribed and the eDNA template for SREBP-2 and P-actin was amplified as 
described in the methods section. The SREBP-2 mRNA expression was normalized 
against P-actin mRNA expression and expressed as relative units. Values given are 
means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different 
letters depict statistically significant differences (p< 0.05). 
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Figure 3.16: Hepatic PP AR-a mRNA expression of BioFlB hamsters fed either fish oil 
(open) or seal oil (shaded), for a period of 4 weeks. Total liver RNA was extracted, 
reverse transcribed and the eDNA template for PP AR-a and ~-actin was amplified as 
described in the methods section. The PP AR-a mRNA expression was normalized 
against ~-actin mRNA expression and expressed as relative units. Values given are 
means ± SEM (n=6) analyzed by unpaired t-test. Mean values shown with different 
letters depict statistically significant differences (p< 0.05). 
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Figure 3.17: Hepatic LXR-a mRNA expression of BioFlB hamsters fed either fish oil 
(open) or seal oil (shaded), for a period of 4 weeks. Total liver RNA was extracted, 
reverse transcribed and the eDNA template for LXR-a and ~-actin was amplified as 
described in the methods section. The LXR-a mRNA expression was normalized against 
~-actin mRNA expression and expressed as relative units. Values given are means ± 
SEM (n=6) analyzed by unpaired t-test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.18: Plasma TBARS levels in BioFlB hamsters fed either fish oil (open) or seal 
oil (shaded) for a period of 4 weeks. Plasma samples were assayed for TBARS as 
described in the methods section. Values given are means ± SEM (n=6) analyzed by 
unpaired-t test. Mean values shown with different letters depict statistically significant 
differences (p< 0.05). 
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Figure 3.19: Hepatic TBARS levels in BioFlB hamsters fed either fish oil (open) or seal 
oil (shaded) for a period of 4 weeks. Liver samples were assayed for TBARS as described 
in the methods section. Values given are means ± SEM (n=6) analyzed by unpaired-t test. 
Mean values shown with different letters depict statistically significant differences (p< 
0.05). 
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Table 3.1 Body weight gain after 4-weeks of dietary treatments in Bio FIB hamsters fed 
either fish oil or seal oil alone or in combination with elderberry extract. 
Diet Type Weight gain (g) 
Fish Oil 19.18±3.58 a 
Fish Oil & 
Elderberry Extract 13.56±3.46 b 
Seal Oil 15.2±2.21 a 
Seal Oil & 
Elderberry Extract 1 0.32±1.56 c 
Values are given as mean± SEM (n=6) 
Dietary groups were analyzed by 2- way ANOV A and the Newman-Keuls post-hoc test 
Mean values shown with different letters depict statistically significant differences (p< 
0.05). 
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3.2 Effect of a combination of marine oils and elderberry extract in BioFlB 
hamsters 
3.2.1 Body weight and diet consumption 
The analysis of weight gain at the end of 4-week period revealed no significant 
differences in hamsters fed fish oil and seal oil diet alone. However, these high fat diets 
when cosupplemented with elderberry extract resulted in significantly lower body weight 
gain in hamsters fed the combination diet compared to hamsters on high fat diet alone 
(Table 3.1 ). While cosupplementation with elderberry extract in fish oil fed hamsters 
resulted in a 29% decrease in body weight gain as compared to hamsters fed fish oil diet 
alone (p= 0.04), a 32% decrease in weight gain was observed for hamsters fed a 
combination of seal oil and elderberry extract than animals fed seal oil alone (p= 0.004). 
Addition of elderberry extract to high fat diets however, did not result in significant 
differences in the average daily food intake (g/day) of BioF1B hamsters (fish oil: 5.41 
± 0.21; fish oil + elderberry extract: 5.30 ± 0.15; seal oil : 6.05 ± 0.56; seal oil + 
elderberry extract: 5.75 ± 0.64). 
3.2.2 Plasma lipids in BioFlB hamsters fed a combination of marine oils and 
elderberry extract 
Fasting plasma samples from hamsters fed fish oil and seal oil alone and those fed 
a combination of marine oils and elderberry extract were analyzed for TG (Figure 3.20), 
total cholesterol (Figure 3.21 ), cholesterol esters (Figure 3 .22) and free cholesterol 
(Figure 3.23) concentrations. All lipid parameters showed significant differences when 
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elderberry extract was added. Two-way AN OVA revealed a significant effect of marine 
oils (p< 0.0001) as well as elderberry extract (p< 0.0001) on plasma TG, total cholesterol, 
cholesterol esters and free cholesterol. One-way ANOVA was also performed, as there 
was a significant interaction between marine oils and elderberry extract (p< 0.0001). 
While fish oil fed BioF 1 B hamsters showed significantly higher levels of plasma 
TG compared to seal oil fed hamsters, addition of elderberry extract to fish oil diet 
resulted in a 90% decrease in the levels of plasma TG compared to BioF 1 B hamsters fed 
fish oil alone (p< 0.001) (Figure 3.20). These levels were comparable to plasma TG 
levels of BioF1B hamsters fed seal oil diet alone. Addition of elderberry extract to seal 
oil further led to a 70% decrease in plasma TG levels as compared to hamsters fed seal 
oil diet alone (p< 0.0001). There was a 80% decrease in plasma total cholesterol 
concentrations in hamsters fed a combination of fish oil and elderberry extract (p = 
0.0005) (Figure 3.21) as compared to feeding fish oil alone. Total cholesterol levels of 
hamsters fed a combination of fish oil and elderberry extract were comparable to 
hamsters fed seal oil alone. Elderberry extract supplementation in the seal oil dietary 
group also showed a 70% lowering of total cholesterol levels as compared to seal oil fed 
hamsters (p< 0. 000 1). 
Plasma cholesterol ester (Figure 3.22) and plasma free cholesterol (Figure 3.23) 
concentrations showed a similar trend to plasma TG and cholesterol concentrations. 
BioF1B hamsters fed a combination of fish oil and elderberry extract had significantly 
lower cholesterol ester (p = 0.0002) and free cholesterol (p = 0.002) concentrations 
compared to fish oil fed hamsters. 
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Figure 3.20: Plasma triglyceride concentrations in BioFlB hamsters fed either fish oil or 
seal oil in the presence (shaded) and absence (open) of elderberry extract for a period of 4 
weeks. Fasting plasma samples were collected and assayed for triglycerides as described 
in the methods section. Values given are means ± SEM (n=6) analyzed by 2-way 
ANOV A and the Newman- Keuls post-hoc test. Mean values shown with different letters 
depict statistically significant differences (p< 0.05). 
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Figure 3.21: Plasma total cholesterol concentrations in BioFlB hamsters fed either fish 
oil or seal oil in the presence (shaded) and absence (open) of elderberry extract for a 
period of 4 weeks. Fasting plasma samples were collected and assayed for total 
cholesterol as described in the methods section. Values given are means ± SEM (n=6) 
analyzed by 2-way ANOV A and the Newman- Keuls post-hoc test. Mean values shown 
with different letters depict statistically significant differences (p< 0.05). 
74 
_j 
15 
- a 
-...J T 
:::::: 
0 
E 
E 10 
-
-
~ 
.s 
~ 
e 
.e 5 
~ 
b 
- -....- b_ 
,;<..; 
0 
s:. 
0 
0 
~ ~ 
~ ~ ~ 
~ ~ :s: _s ~ ~ .;<... 
Fish Oil Seal Oil 
Figure 3.22: Plasma cholesterol ester concentrations in BioFlB hamsters fed either fish 
oil or seal oil in the presence (shaded) and absence (open) of elderberry extract for a 
period of 4 weeks. Fasting plasma samples were collected and assayed for cholesterol 
esters as described in the methods section. Values given are means ± SEM (n=6) 
analyzed by 2-way ANOVA and the Newman- Keuls post-hoc test. Mean values shown 
with different letters depict statistically significant differences (p< 0.05). 
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Figure 3.23: Plasma free cholesterol concentrations in BioFlB hamsters fed either fish 
oil or seal oil in the presence (shaded) and absence (open) of elderberry extract for a 
period of 4 weeks. Fasting plasma samples were collected and assayed for free 
cholesterol as described in the methods section. Values given are means ± SEM (n=6) 
analyzed by 2-way ANOV A and the Newman- Keuls post-hoc test. Mean values shown 
with different letters depict statistically significant differences (p< 0.05). 
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The levels of cholesterol esters and free cholesterol of BioF1B hamsters fed a 
combination of fish oil and elderberry extract were similar to the levels observed for 
hamsters fed seal oil diet. Addition of elderberry extract to seal oil diet further reduced 
the levels of cholesterol esters (p< 0.0001) and free cholesterol (p< 0.0001) as compared 
to hamsters fed seal oil alone. 
3.2.3 Liver lipids of hamsters fed a combination of marine oils and elderberry 
extract 
Hepatic TG concentrations of hamsters fed either fish oil or seal oil alone or a 
combination of marine oils and elderberry extract are given in Figure 3.24. Two-way 
ANOV A revealed significant differences in different dietary groups in response to fat 
type (p= 0.04), elderberry extract (p= 0.01) and interaction between fat and elderberry 
extract (Fat*elderberry extract; p= 0.01). BioF1B hamsters fed a combination of fish oil 
and elderberry extract showed significantly lower TG concentrations (p< 0.001 ) as 
compared to hamsters fed fish oil alone. In contrast, the combination of seal oil and 
elderberry extract had no effect on hepatic TG levels as compared to hamsters fed seal oil 
alone. 
Liver total cholesterol concentrations were significantly different in response to 
different marine oils and elderberry extract (Figure 3.25). Hepatic total cholesterol 
concentrations were significantly reduced when BioF1B hamsters were· fed marine oils 
along with elderberry extract as compared to the respective fat diet alone (p< 0.001 for 
fish oil treated hamsters and p< 0.05 for the seal oil fed hamsters). 
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Figure 3.24: Hepatic triglyceride concentrations in BioFlB hamsters either fed fish oil or 
seal oil in the presence (shaded) and absence (open) of elderberry extract for a period of 4 
weeks. Liver samples were assayed for triglycerides as described in the methods section. 
Values given are means ± SEM (n=6) analyzed by 2-way ANOVA and the Newman-
Keuls post-hoc test. Mean values shown with different letters depict statistically 
significant differences (p< 0.05). 
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Figure 3.25: Hepatic total cholesterol concentrations in BioFlB hamsters fed either fish 
oil or seal oil in the presence (shaded) and absence (open) of elderberry extract for a 
period of 4 weeks. Liver samples were assayed for total cholesterol as described in the 
methods section. Values given are means± SEM (n=6) analyzed by 2-way ANOVA and 
the Newman- Keuls post-hoc test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.26: Hepatic cholesterol ester concentrations in BioFlB hamsters fed either fish 
oil or seal oil in the presence (shaded) and absence (open) of elderberry extract for a 
period of 4 weeks. Liver samples were assayed for cholesterol esters as described in the 
methods section. Values given are means± SEM (n=6) analyzed by 2-way ANOVA and 
the Newman- Keuls post-hoc test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Figure 3.27: Hepatic free cholesterol concentrations in BioFlB hamsters fed either fish 
oil or seal oil in the presence (shaded) and absence (open) of elderberry extract for a 
period of 4 weeks. Liver samples were assayed for free cholesterol as described in the 
methods section. Values given are means± SEM (n=6) analyzed by 2-way ANOVA and 
the Newman- Keuls post-hoc test. Mean values shown with different letters depict 
statistically significant differences (p< 0.05). 
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Analysis of hepatic cholesterol esters revealed significant differences in response 
to different dietary treatments (Figure 3.26). Similar to total cholesterol concentrations, 
cholesterol esters were also significantly reduced in BioFIB hamsters fed a combination 
of marine oils and elderberry extract as compared to hamsters fed the respective fat diet 
alone (p< 0.001 for fish oil and seal oil fed hamsters). 
Hepatic free cholesterol levels were also influenced by treatment with marine oils 
(p< 0.0001) as well as elderberry extract (p< 0.01) (Figure 3.27). A combination of fish 
oil and elderberry extract caused a significant reduction in hepatic free cholesterol 
concentrations as compared to hamsters fed fish oil alone (p= 0.04). However, no 
significant difference was observed in the seal oil fed hamsters in the presence or absence 
of elderberry extract. 
3.2.4 Plasma and liver TBARS of hamsters fed marine oils and elderberry extract 
Figure 3.28 shows plasma TBARS levels to evaluate the extent of lipid 
peroxidation in response to different diets. Two-way ANOV A revealed a significant 
effect of fat and elderberry extract (p< 0.0001 and 0.001 respectively) on plasma lipid 
peroxide concentrations in hamsters fed different diets. Seal oil fed BioF 1 B hamsters had 
significantly lower levels of lipid peroxides (p< 0.001) compared to fish oil fed hamsters. 
A combination of fish oil and elderberry extract significantly reduced plasma TBARS as 
compared to hamsters fed fish oil alone (p< 0.001). In contrast to fish oil fed hamsters, a 
combination of seal oil and elderberry extract had no significant effect on plasma TBARS 
as compared to hamsters fed seal oil alone. 
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Liver TBARS from hamsters fed different marine oils in the absence or presence 
of elderberry extract are shown in Figure 3.29. Fish oil fed hamsters had significantly 
higher levels of liver TBARS as compared to seal oil fed hamsters (p< 0.01). Addition of 
elderberry extract to fish oil fed BioFIB hamsters significantly reduced liver TBARS as 
compared to hamsters fed fish oil alone. On the other hand, addition of elderberry extract 
to seal oil had no significant effect on liver TBARS as compared to seal oil alone fed 
hamsters. 
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Figure 3.28: Plasma TBARS levels in BioFl B hamsters fed either fish oil or seal oil in 
the presence (shaded) and absence (open) of elderberry extract for a period of 4 weeks. 
Plasma samples were assayed for TBARS as described in the methods section. Values 
given are means± SEM (n=6) analyzed by 2-way ANOV A and the Newman- KeuJs post-
hoc test. Mean values shown with different letters depict statistically significant 
differences (p< 0.05). 
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Figure 3.29: Hepatic TBARS levels in BioFIB hamsters fed either fish oil or seal oil in 
the presence (shaded) and absence (open) of elderberry extract for a period of 4 weeks. 
Liver samples were assayed for TBARS as described in the methods section. Values 
given are means± SEM (n=6) analyzed by 2-way ANOV A and the Newman- Keuls post-
hoc test. Mean values shown with different letters depict statistically significant 
differences (p< 0.05). 
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Chapter 4: Discussion 
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4.1 Effects of dietary fish oil in BioFlB hamsters 
Previous studies from our laboratory have shown that high levels of fish oil cause 
hyperlipidemia in BioFlB hamsters (de Silva et al. , 2004). These hamsters showed milky 
plasma rich in CM like particles and significantly elevated plasma-, VLDL-, LDL-
cholesterol and TG concentrations. While there is a possibility that fish oil induced 
hyperlipidemia could partly be contributed by VLDL fraction, however, CM appears to 
be the major candidate. Subsequent findings demonstrated that diet induced 
hyperlipidemia in BioFlB hamsters were specific to fish oil compared to a diet rich in 
MUF A or ro-6/ ro-3 diet (Cheema and Cornish, 2007). Presence of milky plasma, rich in 
CM like particles, in fish oil fed BioFlB hamsters indicated that fish oil feeding either 
affected the synthesis and secretion or clearance of TG-rich lipoproteins. Diet induced 
hyperlipidemia was partly explained by reduced post-heparin LPL activity and thus, 
appeared to have hindered the clearance of CM- like particles from circulation. For the 
present study, we hypothesized that BioFlB hamsters will be able to metabolize seal oil 
better than fish oil due to differences in fatty acid composition and the positional 
distribution of fatty acids in the TG molecule. We had previously established that fish oil 
feeding in BioFlB hamsters led to increased lipid peroxidation and compromised anti-
oxidant status as compared to the other diets (Dubey and Cheema, unpublished data). 
Thus, we compared the effects of fish oil and seal oil on the regulation of lipid 
metabolism and oxidative stress in BioFlB hamsters. 
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4.2 Effect of dietary fish oil or seal oil on plasma lipids 
4.2.1 Effect of dietary fish oil or seal oil on plasma TG 
Feeding a high fat seal oil diet for 4 weeks to BioF1B hamsters did not cause 
milky plasma after an overnight fast (Figure 3.1 ). The whole plasma (Figure 3 .2) and 
individual lipoprotein fractions (Figure 3.3) showed significantly lower TG 
concentrations in seal oil fed hamsters as compared to hamsters fed fish oil. Other studies 
have also reported significantly higher TG concentrations in fish oil fed rabbits and 
hamsters (Kristensen et al. , 1988; Hayes et al. , 1992; Kubow et al. , 1996). The absence 
of milky plasma and significantly lower plasma TG levels in BioF1B hamsters fed seal 
oil as compared to fish oil fed hamsters suggested differences in the clearance of TG rich 
lipoproteins. Hydrolysis of TG in circulating CM and VLDL to FF A and glycerol by LPL 
represents a rate-limiting step in the clearance of these TG-rich lipoproteins from the 
circulation. Reduced post-heparin LPL activity has been associated with an increased 
accumulation of CM in BioFlB hamsters fed a cholesterol supplemented diet (McAteer 
et al., 2003). Significantly lower post-heparin LPL activity was observed in BioF1B 
hamsters compared to Golden Syrian hamsters which was further reduced by fish oil 
feeding (Cheema and Cornish, 2007). BioFlB hamsters also showed significantly 
reduced adipocyte LPL mRNA levels as compared to Golden Syrian hamsters indicating 
variations in genetic background between the two hamster strains. It appears that lower 
levels of LPL may be sufficient to clear lower density lipoproteins from seal oil fed 
hamsters as compared to fish oil fed hamsters, likely due to positional distribution of fatty 
acids in the triglyceride molecule. 
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Both fish oil and seal oil are rich sources of co-3 PUF A with fundamental 
differences in the composition and intramolecular distribution of co-3 PUF A. In addition 
to EPA and DHA found in fish oil, seal oil contains higher levels of DP A. Christensen et 
al. (1994) showed that while EPA and DHA are primarily located in sn-2 position in fish 
oil TG, these are distributed in sn-1 and sn-3 positions in seal oil TG. These structural 
differences may play an important role in the differential metabolism of these oils in the 
BioFIB hamsters. The pancreatic lipase and gastrointestinal lipase hydrolyze primary 
ester bonds in TG. While co-3 PUP A from fish oil are primarily absorbed as sn-2 
monoglycerols, these are absorbed as FF A upon seal oil consumption. It is suggested that 
differences in intramolecular distribution of co-3 PUP A in the two marine oils can 
potentially alter their uptake and bioavailability. Previous studies have shown a faster 
clearance of seal oil CM compared to fish oil CM (Christensen et al., 1995). Yoshida et 
al. (1999) have also demonstrated seal oil to be more effective than fish oil in reducing 
serum and liver TG levels. These findings are in support of our observations for the 
absence of CM like particle enriched plasma in seal oil fed BioF1B hamsters compared to 
fish oil fed hamsters. 
4.2.2 Effect of dietary fish oil or seal oil on plasma cholesterol levels 
In the present study, whole plasma total cholesterol (Figure 3.4), cholesterol esters 
(Figure 3.6) and free cholesterol (Figure 3.8) concentrations were significantly lower in 
seal oil fed BioFIB hamsters as compared to fish oil fed BioF1B hamsters. Additionally, 
significant reductions in total cholesterol, cholesterol esters and free cholesterol 
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concentrations were observed in the individual lipoprotein fractions namely VLDL, LDL 
and HDL, in BioFlB hamsters fed seal oil as compared to those fed fish oil. 
While several studies on fish oil supplementation have reported reduced VLDL 
cholesterol levels, the effects of fish oil on plasma total and LDL-cholesterol 
concentrations are inconsistent. Though some studies show lower LDL-cholesterollevels 
in response to dietary fish oil, others reveal high plasma total- and LDL- cholesterol 
concentrations upon fish oil feeding (Neste! et al. , 1984; Sullivan et al, 1986; Hsu et al. , 
2000; Rivellese et al. , 2003). Genetic susceptibility to dyslipidemia in certain populations 
can further result in elevated LDL-cholesterol levels upon fish oil supplementation. In 
fact, our laboratory has reported increased plasma VLDL and LDL- cholesterol 
concentrations in fish oil fed BioF1B hamsters as compared to hamsters fed a mixture of 
lard and safflower oil (1.5:1) (de Silva et al., 2004). It was previously reported that both 
fish oil and seal oil significantly lowered plasma total cholesterol concentrations as 
compared to com oil fed guinea pigs (Murphy et al. , 1999b ). However, no significant 
differences in total cholesterol, LDL-cholesterol and HDL cholesterol were observed in 
fish oil and seal oil fed normocholesterolemic subjects as well as moderately 
hypercholesterolemic subjects (V ognild et al. , 1998; Conquer et al. , 1999; Brox et al., 
2001). Recently, a study on dietary response to ro-3 PUFA in hypertriglyceridemic 
volunteers revealed reductions of 7% and 14% in plasma triglyceride levels of fish oil 
and seal oil fed subjects respectively, compared to control group (Meyer et al. , 2009). 
Moreover, our findings show that dietary seal oil fed BioF1B hamsters had lower 
cholesterol concentrations as compared to fish oil fed BioF1B hamsters. These data 
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further suggest that genetic variability might be crucial in determining any differential 
response of ro-3 PUF A supplementation on lipid profile and other biological variables, 
based on the type of ro-3 PUF A fed. 
Preliminary observations from our laboratory show that the CM fatty acid 
composition is different in fish oil fed and seal oil fed BioF1B hamsters (Banfield, 2008). 
Fatty acid analysis showed significantly higher EPA and DHA concentrations in CM 
from fish oil fed BioF 1 B hamsters compared to seal oil fed BioF 1 B hamsters. These 
findings suggest that the uptake and/or removal of these fatty acids might not be as 
efficient in fish oil fed BioF1B hamsters as compared to seal oil fed BioF1B hamsters. 
Fish oil feeding in BioF1B hamsters has also been shown to lower LPL activity compared 
to BioF1B hamsters fed MUFA and ro-6/ ro-3 diets (Cheema and Cornish, 2007). In 
addition to regulating energy distribution in the form of free fatty acids, LPL is also 
known to play an important role in lipoprotein metabolism by controlling the distribution 
of cholesterol to LDL and HDL (Tsutsurni, 2003). LPL-mediated hydrolysis of VLDL 
leads to the formation of LDL, which is considered to be an independent predictor of 
CVD. LPL is a rate-limiting enzyme in the formation of LDL particles; structural 
mutations in the LPL gene have revealed a genetic linkage to LDL particle size 
(Hokanson et a!. , 1999). A clinical study reported by Ando et a!. (200 1) has shown 
genetic LPL deficiency to be associated with hypercholesterolemia due to increased 
VLDL and LDL levels. Over expression of LPL in transgenic Watanabe heritable 
hyperlipidemic rabbits significantly suppressed high fat diet induced hyperlipidemia, 
suggesting therapeutic potential of LPL genetic manipulation in human Familial 
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Hypercholesterolemia (Koike eta!. , 2004). In our study, it appears that BioFlB hamsters 
with reduced LPL activity clear CM and VLDL more efficiently in response to dietary 
seal oil as compared to fish oil. Plasma LDL cholesterol levels have been negatively 
correlated with the rate of clearance of TG-rich lipoproteins from plasma (Chung eta!. , 
2004; Sposito et a!. , 2002). This further supports our hypothesis that hindered TG-rich 
lipoprotein clearance in fish oil fed BioFlB hamsters contributes to elevated plasma LDL 
levels. However, to date there are no reports on the association of altered clearance of 
TG-rich lipoproteins and plasma cholesterol levels in seal oil and fish oil fed BioFlB 
hamsters as well as the molecular mechanisms involved. The possibility of fat 
malabsorption in differentially fed hamsters also needs to be explored. Thus, more 
elaborate studies to investigate the differential regulation of VLDL, LDL and HDL 
cholesterol levels in fish oil and seal oil fed BioFlB hamsters need to be carried out. 
The differential regulation of lipoprotein metabolism by the two ro-3 rich PUF A 
sources in BioFlB hamsters could also involve LDL receptor, which is important in the 
clearance of lipoprotein cholesterol from the circulation. Theobald eta!. (2004) reported 
elevated LDL cholesterol concentrations and reduced LDL receptor expression after 
DHA consumption (0.7g/day) in middle aged men and women for 3 months. Similarly, 
fish oil induced hyperlipidemia in BioFlB hamsters revealed significantly lower hepatic 
LDL-receptor mRNA levels as compared to ro-6/ ro-3 diet fed hamsters (de Silva et al. , 
2004). It still remains to be explored whether ro-3 PUF A in seal oil exert any effect on 
LDL receptor gene expression and alter lipoprotein clearance. 
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Lecithin:cholesterol acyl transferase (LCA T) and CETP play a major role in 
"reverse cholesterol transport", a process which facilitates the removal of free cholesterol 
from extrahepatic tissues and transports cholesterol to liver. In the plasma, LCA T and 
CETP mediate the esterification of free cholesterol as well as reciprocal exchange of 
cholesterol esters and TG between cholesterol-rich lipoproteins (LDL and HDL) and TO-
rich lipoproteins (CM and VLDL) (Chung et al., 2004; Tall 1993; Glomset and Norum, 
1973). Reduced CETP activity has been demonstrated in the plasma of patients with LPL 
deficiency (Bagdade et al., 1996). Differential regulation of LCA T and CETP might 
partially account for differences in the rate of clearance of TG-rich lipoproteins as well as 
cholesterol levels in response to two marine oils in BioF 1 B hamsters. Thus, precise 
mechanisms involved in differential regulation of lipid metabolism by the two co-3 PUF A 
rich marine oils, especially with regards to heterogeneity in genetic background need to 
be studied in detail. 
4.2.3 Effect of dietary fish oil or seal oil on hepatic lipid profile 
We observed significantly lower hepatic TG, total-cholesterol, cholesterol esters 
and free cholesterol levels in seal oil fed BioFlB hamsters as compared to fish oil fed 
BioFlB hamsters (Figure 3.10 - Figure 3.13). Elevated hepatic lipid levels have 
previously been shown from our laboratory in fish oil fed BioFlB hamsters (de Silva et 
al. , 2004, Cheema and Cornish, 2007). While all the hepatic lipid parameters were 
significantly lower in seal oil fed BioFlB hamsters as compared to the fish oil fed 
BioFlB hamsters, the differences for hepatic total- cholesterol and cholesterol esters were 
93 
more dramatic as compared to the hepatic TG and free cholesterol concentrations in 
BioFlB hamsters fed dietary seal oil. Seal oil fed BioFlB hamsters showed almost 50% 
lower hepatic total cholesterol and cholesterol ester concentrations, which suggests that 
seal oil specifically alters the regulation of metabolic pathways involved in cholesterol 
metabolism in the liver. 
Liver is believed to be the most important organ in cholesterol regulation and the 
metabolic mechanisms that influence hepatic free cholesterol and cholesterol ester levels 
are critical in maintaining total body cholesterol homeostasis. Since cholesterol primarily 
contributes to the development of CVD by accumulating in the arterial plaques as 
cholesterol esters (Rudel and Shelness, 2000), it is important to study in detail the 
transport and storage of cholesterol in BioF 1 B hamsters fed marine oils. A key 
cholesterol esterification enzyme, acyl Co A: cholesterol acyl transferase 2 (ACA T -2) is 
expressed in the liver and intestine. Cholesterol esters generated by ACAT-2 in the 
intestine are incorporated into CM and are rapidly and selectively removed from the 
circulation by the liver (Klein and Rudel, 1983, Goodman, 1962). ACAT-2 further 
regulates hepatic cholesterol metabolism as well as the secretion and transport in plasma 
lipoproteins (Rudel and Shelness, 2000). ACAT also regulates biliary cholesterol 
secretion by influencing the availability of "metabolically active" free cholesterol for 
transport into bile (Turley and Dietschy, 1988). ACAT -2 deficient mice have been shown 
to be resistant to diet-induced hypercholesterolemia with reduced capacity to absorb 
cholesterol (Buhman et al. , 2000). These authors reported that disruption of cholesteryl 
ester formation in the intestine by ACA T -2 prevents cholesteryl ester accumulation in the 
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liver, within lipoprotein particles as well as in the bile. Since we observed drastic 
differences in the cholesterol levels of fish oil and seal oil fed BioFlB hamsters with 
more pronounced changes in total cholesterol and cholesteryl ester levels, it will be 
interesting to study any effects of different diets on ACAT expression and activity. 
Contrary to the role of ACAT, cholesteryl ester hydrolase (CEH) hydrolyses 
cholesteryl esters to generate free cholesterol. When cellular free cholesterol levels are 
depressed, cytosolic CEH releases free cholesterol from the intracellular cholesteryl ester 
storage, thus contributing to maintaining a constant cellular free cholesterol pool (Ghosh 
and Grogan, 1989; Ghosh et al. , 1990; Lee and Carr, 2004). Regulation of CEH in the 
liver mainly occurs at the transcriptional level (Grogan et al., 1991 ; Ghosh et al. , 1998). 
ACAT and CEH are likely to be coordinately regulated since they act together in a cyclic 
and opposite manner (Lee and Carr, 2004). It remains to be ascertained whether fish oil 
and seal oil differently regulate CEH expression and activity in BioFlB hamsters. 
Interestingly, gas chromatography analysis of the two co-3 PUFA rich diets 
revealed that the MUF A content in seal oil was more than double of that found in fish oil 
(22.2% in fish oil and 50.6% in seal oil). These observations lead us to believe that 
increased MUF A content of seal oil diet might partially account for significantly lower 
hepatic total cholesterol and cholesterol ester levels in seal oil fed BioF 1 B hamsters as 
compared to fish oil fed BioFlB hamsters, along with differential regulation of 
transcription factors as discussed in the following sections. 
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4.2.4 Effect of dietary fish oil or seal oil on mRNA expression of transcription 
factors 
Dramatic effects of ro-3 PUF A rich marine oils, namely fish oil and seal oil, on 
plasma and liver lipid profile suggest that the two marine oils might be differentially 
regulating the molecular mechanisms involved in lipid and lipoprotein metabolism. Thus 
we investigated whether the differences in gene regulation by fish oil and seal oil were 
evident at the level of transcription factors and nuclear receptors, i.e. SREBP-1c, 
SREBP-2, LXR-a and PPAR-a. 
4.2.4.1 Effect of dietary fish oil or seal oil on SREBP mRNA expression 
Regulation of lipid metabolism involves SREBPs, helix-loop-helix transcription 
factors, which bind to the sterol regulatory elements in promoters of genes involved in 
lipogenesis and cholesterol metabolism (Sam path and Ntambi, 2005). While SREBP-1 c 
preferentially activates lipogenesis, SREBP-2 preferentially enhances the transcription of 
genes involved in cholesterogenesis (Le Jossic-Corcos eta!., 2005). In our study, seal oil 
fed BioFlB hamsters showed significantly reduced hepatic SREBP-1c mRNA expression 
as compared to the fish oil fed BioF1B hamsters (Figure 3.14). The suppression of 
lipogenesis in seal oil fed BioF1B hamsters can be partially explained by reduced 
SREBP-1 c mRNA levels. On the other hand, fish oil and seal oil fed hamsters did not 
show any significant differences in hepatic SREBP-2 mRNA levels (Figure 3.15), though 
there was a trend towards reduced SREBP-2 mRNA expression in seal oil fed BioF 1 B 
hamsters compared to the fish oil fed BioF 1 B hamsters. 
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Dietary ro-3 PUF A can exert an inhibitory effect on lipogenesis either by 
inhibition of SREBP maturation or repression of SREBP mRNA. In addition to 
regulation of SREBP-1 proteolytic degradation by ro-3 PUF A in vivo (Xu et al. , 1999b; 
Kim et al. , 1999), some studies have reported lower intracellular levels of SREBP-1 c 
mRNA in response to dietary ro-3 PUFA (Kim et al., 1999; Yahagi eta!., 1999). These 
suppressive effects of dietary fish oil on the expression of lipogenic enzymes at the level 
of SREBP-1 mRNA expression as well as proteolytic processing of mature SREBP-1 
have been reported in rodent liver and human cell lines (Kim et al. , 1999; Hannah et al., 
2001). Similar to our findings with seal oil supplementation in BioF1B hamsters, EPA 
and DHA treatment in H4IIEC3 cells showed reduced levels of SREBP-1c mRNA 
expression, with no changes seen with SREBP-1a and SREBP-2 levels (Le Jossic-Corcos 
et al. , 2005). 
Thus, lower SREBP-1c mRNA levels in seal oil fed BioF1B hamsters indicate a 
potential role of SREBP-1 c in differential regulation of lipogenesis in response to the 
marine oils in BioF 1 B hamsters. However, it needs to be elucidated whether the 
regulation of SREBP-1 c levels occurs at the level of mRNA synthesis or mRNA stability. 
Moreover, no significant differences in SREBP-2 mRNA expression were seen in fish oil 
and seal oil fed BioF 1 B hamsters. This may suggest that either SREBP-2 is not involved 
in regulating lipid levels in response to the high fat diets or the diets might exert 
differential effects on lipid metabolism via SREBP-2 activation at translational or post-
translational level. Further studies are needed to elucidate precise downstream effectors · 
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of differential SREBP-lc expression that contribute to the anti-hyperlipidemic outcome 
in seal oil fed BioFlB hamsters. 
4.2.4.2 Effect of dietary fish oil or seal oil on PPAR-a mRNA expression 
PPAR-a is predominantly found in the liver and regulates genes of lipid transport 
and oxidation. Since the two different co-3 PUF A rich sources in our study showed drastic 
alterations in plasma and liver lipid profile, we investigated whether there were 
alterations in the regulation of hepatic PP AR- a expression levels in fish oil and seal oil 
fed BioFlB hamsters. We did not observe any significant differences in PPAR-a 
expression in response to fish oil or seal oil feeding in BioFlB hamsters (Figure 3.16). 
Nakatani et al. (2003) has previously reported an activation of PPAR-a in rodents fed fish 
oil. Increased hepatic expression of PPAR-a in fish oil fed mice also demonstrated 
increased expression of peroxisomal and microsomal fatty acid oxidation genes (Larter eL 
al. , 2008). The expression of several PP AR dependent enzymes mediating fatty acid 
oxidation was also significantly increased upon menhaden oil supplementation in the 
livers of corpulent JCR rats (Deng et al. , 2004 ). Structural analysis had demonstrated that 
EPA is an endogenous ligand for PP ARs while DHA needs to be converted to EPA to 
activate PP ARs (Xu et al. , 1999a; Sprecher 2000). Though the two marine oils in our 
study differ in their co-3 PUF A composition and MUF A content, these changes did not 
seem to significantly alter the hepatic PPAR-a expression. Thus, the observed changes in 
plasma and hepatic lipids by seal oil and fish oil feeding in the BioFlB hamsters were not 
due to alterations in the mRNA expression ofPPAR- a. 
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4.2.4.3 Effect of dietary fish oil or seal oil on LXR-a. mRNA expression 
LXR -a and -~ are believed to be involved in the regulation of several genes of 
lipid metabolism, e.g. Cyp7a, FAS, LPL, ACC. The transcription of SREBP-lc has also 
been shown to be under the positive control of LXR- a (Repa eta/. , 2000). While some 
studies suggest that SREBP-mediated repression of lipogenesis by PUF A is LXR 
dependent (Yoshikawa et a/. , 2002b ), others propose that repression of SREBP-1 c 
mRNA levels by PUF A is LXR-independent (Pawar et al., 2003). Since we observed 
reduced SREBP-lc mRNA levels in seal oil fed BioFIB hamsters as compared to fish oil 
fed BioF1B hamsters, we decided to elucidate the effects of marine oils on LXR-a 
expression in BioF 1 B hamsters. Our results did not show any significant differences in 
hepatic LXR-a mRNA expression in the fish oil and seal oil fed BioFlB hamsters (Figure 
3.17). Thus, the effect of seal oil on SREBP-lc inhibition is likely due to LXR-
independent pathways. 
4.2.5 Effect of dietary fish oil or seal oil on plasma and liver lipid peroxidation 
The consumption of long chain PUFA, i.e. ro-3 PUFA in marine oils, can confer 
increased susceptibility to oxidative stress. Dietary ro-3 PUF A has been shown to 
displace ro-6 PUF A and get efficiently incorporated into membrane phospholipids. 
Leibovitz et a/. (1990) reported that membranes rich in ro-3 PUF A were more prone to 
oxidative stress. Previous studies from our laboratory demonstrated significantly higher 
liver lipid peroxidation levels in BioFlB hamsters as compared to Golden Syrian 
hamsters (Dubey and Cheema, unpublished data). BioFlB hamsters fed fish oil showed 
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significant elevations in liver lipid peroxidation levels as compared to BioFIB hamsters 
on MUFA and ro-6/ ro-3 diets. We observed reduced catalase activity in fish oil fed 
BioFIB hamsters as compared to ro-6/ ro-3 diet fed BioFIB hamsters. These findings 
support several reports in which fish oil supplementation has been shown to enhance in-
vivo lipid peroxidation and compromise anti-oxidant enzyme status and potentially 
contribute to atherogenesis (Kaasgaard et a/.,1992; Cho eta!., 1995; Ando et al. , 1998; 
Ando eta!. , 2000; Dommels eta!., 2003; Yuan and Kitts, 2003). Fish oil induced lipid 
peroxidation has been associated with fish oil induced hyperlipidemia (Kubow, 1998). 
Hence, the elevations in lipid peroxide levels and compromised anti-oxidant defenses in 
fish oil fed BioF 1 B hamsters can also potentially contribute to fish oil induced 
hyperlipidemia in BioF 1 B hamsters. In contrast to most studies that propose detrimental 
effects of dietary fish oil on oxidative stress, other studies report beneficial effects of fish 
oil against oxidation (Erdogan et al. , 2004; Wang et al. , 2004). 
In the present study, we compared the effects of dietary fish oil and seal oil on the 
extent of oxidative stress in BioF1B hamsters. It was observed that both plasma (Figure 
3 .18) and liver (Figure 3 .19) lipid peroxidation levels were significantly lower in seal oil 
fed hamsters as compared to fish oil fed BioF1B hamsters. However, the plasma TBARS 
levels showed more dramatic differences as compared to the liver TBARS. The plasma 
malondialdehyde levels in seal oil fed BioFlB hamsters were almost one-third of that 
observed for fish oil fed BioF1B hamsters. The possible explanation for differences in 
oxidation levels in response to the two ro-3 PUFA rich marine oils could be due to the 
fact that ro-3 PUF A from seal oil are relatively more stable and less prone to lipid 
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oxidation than fish oil (Nakhla, 1997). Furthermore, while high levels of MUF A in seal 
oil diet compared to fish oil can also potentially confer resistance to oxidation, there is a 
possibility that an as yet unknown antioxidant in seal oil might be responsible for its 
resistance to oxidation. Our findings suggest that seal oil feeding does not induce 
oxidative stress as compared to dietary fish oil in BioFIB hamsters. The effect of two 
different sources of ro-3 PUF A on anti-oxidant enzyme activities in seal oil and fish oil 
fed BioFlB hamsters remains to be investigated. More studies need to be undertaken to 
gain a better understanding of the potential beneficial effects of seal oil as an alternative 
source of ro-3 PUFA compared to fish oil in BioFlB hamsters. 
4.3 Effects of a combination of marine oils and elderberry extract 
Recent studies have focused on the investigation of biological anti-oxidants such 
as anthocyanins. Several plant anthocyanins have been reported to be more potent anti-
oxidants when compared to traditional vitamins such as vitamin E and vitamin C (Tsao 
and Deng, 2004; Bakowska-Barczak et al. , 2007). The potential health benefits of 
anthocyanins have mainly been attributed to their anti-atherogenic and anti-oxidant 
properties. Since our preliminary findings showed higher oxidative stress in fish oil 
BioFlB hamsters as compared to MUFA and ro-6/ ro-3 diets, we investigated the effects 
of co-supplementation of anthocyanin-rich elderberry extract (25% w/w) along with high 
fat diets rich in fish oil or seal oil. 
There was no significant effect on the average food intake upon dietary 
supplementation with anthocyanin-rich elderberry extract when given with either fish oil 
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or seal oil. At the end of the 4-week treatment period, there was no significant change in 
the weight gain data for BioFlB hamsters fed fish oil or seal oil alone. However, 
cosupplementation with elderberry extract in BioFlB hamsters fed high fish oil and seal 
oil diets resulted in significant reductions in weight gain after 4-weeks treatment (29% 
decrease in fish oil group and 32% decrease in seal oil group (Table 3.1). These 
observations support the existing reports about the possible anti-obesity effects of 
anthocyanins. Tsuda et al. (2003) demonstrated that dietary cyanidin-3 glucoside rich 
purple com color significantly suppressed the high-fat diet induced increase in body 
weight gain as well as white and brown adipose tissue weights in mice. Anthocyanin 
treatment in C57BL/6 mice fed high fat diet showed about 24% decrease in body weight 
gain (Jayaprakasam et al., 2006). Similarly, rats fed high fat diet and black soybean 
anthocyanins showed significantly lower weight gain than the rats fed high fat diet alone 
(Kwon et al. , 2007). Oral administration of anthocyanins-rich Hibiscus sabdariffa 
resulted in significantly reduced body weight gain in obese mice (Alarcon-Aguilar eta!. , 
2007). Overall, these reports suggest that anthocyanins might influence various metabolic 
pathways and thus exert potential beneficial effects in ameliorating obesity. 
4.3.1 Effect of marine oils and elderberry extract on plasma lipid and lipoprotein 
profile 
Anthocyanins might have preventative effects on the progression of CVD due to 
their lipid-lowering properties. We investigated the role of anthocyanin-rich elderberry 
extract supplementation on plasma lipid levels in marine oil fed BioF 1 B hamsters. An 
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observation of great significance was that BioF1B hamsters fed high fat fish oil diet along 
with elderberry extract did not show milky plasma. All the lipid parameters namely 
plasma TG, total-cholesterol, cholesteryl esters and free cholesterol concentrations were 
significantly reduced upon addition of elderberry extract to the marine oils in BioFIB 
hamsters (Figure 3.20 - Figure 3.23). These observations are in support of earlier reports 
on hypolipidemic effects of anthocyanin supplementation in several experimental animals 
(Kwon et a!. , 2007; Valcheva et a!., 2007 (a, b). The hypolipidemic effects of 
anthocyanins have further been reported to retard the progression of atherogenesis. 
Supplementation of anthocyanin rich black rice to rabbits significantly improved the lipid 
profile and inhibited atherosclerotic plaque formation (Ling et a!., 2001; Ling et a!. , 
2002). Xia et a!. (2006) also showed that anthocyanin rich extract from black nee 
improved lipid profile and enhanced plaque stabilization in ApoE deficient mice. 
Our experimental model for increased susceptibility to diet induced 
hyperlipidemia, BioF 1 B, showed lipid lowering effects of anthocyanin rich elderberry 
extract in both fish oil and seal oil fed hamsters. The reductions in plasma lipid levels 
were more pronounced in the fish oil fed hamsters as compared to the seal oil fed 
hamsters. Interestingly, for all the studied lipid parameters, we noted that the lipid levels 
for the fish oil fed hamsters along with elderberry extract were comparable to those seen 
for the seal oil alone fed Bio FIB hamsters. Moreover, plasma lipid concentrations in seal 
oil fed hamsters were similar to MUFA supplemented BioF1B hamsters. Our results 
suggest that supplementing anthocyanin rich elderberry extract in BioF1B hamsters fed 
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fish oil more effectively lowered lipid levels due to the inherent susceptibility of BioFIB 
hamsters to high dietary fish oil induced hyperlipidemia. 
The mechanism of action of elderberry extract on the regulation of lipid and 
lipoprotein metabolism in experimental animals or humans is not known. Berry extract 
can potentially regulate numerous pathways involved in the lipoprotein metabolism, i.e. 
the synthesis or clearance of TG-rich lipoproteins or cholesterol transporting lipoproteins. 
Absence of milky plasma in BioFlB hamsters fed fish oil and elderberry extract strongly 
suggests a role of elderberry extract in promoting lipoprotein clearance, which is 
inhibited in high fish oil fed BioFlB hamsters. The hypolipidemic action of dietary 
blueberry extract has been suggested to be due to improved TG-rich lipoprotein clearance 
in ethanol-treated normolipidemic and in genetically hyperlipidemic Yoshida rats 
(Cignarella et al., 1996). These authors concluded that supplementing blueberry extract 
might prove to be beneficial for treating dyslipidemias associated with impaired TG-rich 
lipoprotein clearance. Since BioFlB hamsters are an experimental model with reduced 
LPL activity, and thus impaired TG-rich lipoprotein clearance, the precise effects of 
elderberry extract on lipoprotein catabolism need to be explored in future studies. 
4.3.2. Effect of marine oils and elderberry extract on liver lipids 
Supplementing elderberry extract in fish oil fed BioFlB hamsters effectively 
lowered hepatic TG (Figure 3.24) and free cholesterol levels (Figure 3.27) in contrast to 
seal oil fed BioFlB hamsters, which did not show any significant change in hepatic TG 
and free cholesterol levels upon elderberry extract supplementation. Previous studies 
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have reported significant reductions in the hepatic TG levels and decreased hepatic lipid 
accumulation in high fat and anthocyanin fed C57BL/6 mice (Jayaprakasam et al. , 2006). 
It appears that elderberry extract was more effective in lowering hepatic TG and free 
cholesterol levels under hyperlipidemic conditions as observed in fish oil fed hamsters. 
Effects of elderberry extract on hepatic TG synthesis and/or the uptake of TG-rich 
lipoproteins by liver need to be explored to understand the mechanisms involved. 
Both fish oil and seal oil fed BioFIB hamsters showed significantly lower hepatic 
total cholesterol (Figure 3.25) and cholesterol ester (Figure 3.26) concentrations upon 
cosupplementation with elderberry extract. These fmdings indicate that anthocyanin rich 
elderberry extract might specifically regulate the cholesterol synthesis and metabolic 
pathways in exerting its anti-hyperlipidemic effects in fish oil and seal oil fed BioF I B 
hamsters. Since we are the first to report lipid lowering effects of elderberry extract in 
fish oil and seal oil fed BioF I B hamsters, there is no existing data on the precise 
metabolic pathways involved in the regulation of cholesterol metabolism by elderberry 
extract. However, a recent report suggested that anthocyanin-rich extract might have 
greater potential against atherosclerosis progression as compared to simvastatin in ApoE-
deficient mice model (Xia et al. , 2006). It is well established that statin class of drugs 
lower plasma cholesterol levels by inhibiting 3-hydroxy-3-methyl-glutaryl-CoA 
reductase, the rate-limiting enzyme in cholesterol biosynthesis. Interestingly, ApoE-
deficient mice on anthocyanin-rich extract demonstrated lower total cholesterol and non-
HDL cholesterol with elevated HDL-cholesterol as compared to those on simvastatin 
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(Xia eta/. , 2006). Such findings emphasize the need to conduct more studies to evaluate 
the metabolic pathways affected by anthocyanins. 
In addition to affecting cholesterol biosynthesis, anthocyanins might also lower 
hepatic cholesterol ester concentrations by inhibiting ACAT activity thereby affecting 
cholesterol absorption and its incorporation into lipoproteins. Inhibition of ACAT activity 
in response to anthocyanin rich elderberry extract might be yet another mechanism for 
the dramatic decrease in hepatic cholesterol ester levels observed in marine oil fed 
BioF1B hamsters. Cranberry extract induced significantly higher LDL-receptor 
expression and increased intracellular cholesterol uptake in hepatocytes in a dose 
dependent manner (Chu and Liu, 2005). This study proposed the beneficial effects of 
berry extract in the clearance of excessive plasma cholesterol from the circulation. 
Anthocyanin rich extract from black rice has been reported to suppress cholesterol 
accumulation in the liver and aorta and significantly ameliorate hypercholesterolemia, 
suggesting a potential role in cholesterol efflux from the tissues (Xia et a/. , 2003). Xia et 
a/. (2005) recently showed that anthocyanins can induce cholesterol efflux from mouse 
peritoneal macrophages and macrophage derived foam cells by increasing gene 
expression of A TP binding cassette A 1, a key mediator of reverse cholesterol transport. 
This study further showed that stimulation of cholesterol efflux by anthocyanins in these 
cells was dependent on the activation of nuclear factors PP AR-y and LXR-a thereby 
suggesting that differential regulation of various nuclear receptors and transcription 
factors by anthocyanins might also play an important role in the regulation of lipid and 
lipoprotein metabolism in BioF1B hamsters. These reports further emphasize the need to 
106 
investigate the anti-hyperlipidemic effects of anthocyanin rich elderberry extract on 
various metabolic mediators as well as nuclear receptors and transcription factors 
involved in lipid and lipoprotein metabolism in marine oil fed BioF 1 B hamsters. 
4.3.3 Effect of marine oils and elderberry extract on plasma and liver lipid 
peroxidation 
Anthocyanins have gained much attention due to their ability to act as potent anti-
oxidants and reactive oxygen species scavengers, thus preventing CVD progression 
(Ramirez-Tortosa et al. , 2001 ; Stintzing et al. , 2002; Kahkonen and Heinonen, 2003, Wu 
et al. , 2004, Bell and Gochenaur, 2006). Vinson et al. (1995) showed that single 
anthocyanin cyanidin-3-0-glucose chloride was more effective in protecting against 
oxidant degradation of LDLs as compared to vitamin C, E and beta-carotene combined. 
On examining the effects of anthocyanin enriched elderberry supplementation on plasma 
TBARS in marine oil fed BioFlB hamsters, we noted significant reductions in the levels 
of plasma lipid peroxidation in fish oil fed BioF1B hamsters in response to elderberry 
extract (Figure 3.28). Supplementation of seal oil fed BioF1B hamsters with elderberry 
extract did not show significant differences in the extent of lipid peroxidation when 
compared to hamsters fed seal oil alone. Similarly, we noted significant lowering of liver 
TBARS for BioF1B hamsters fed elderberry extract and fish oil as compared to hamsters 
fed fish oil alone (Figure 3.29). No significant changes for liver TBARS were seen in 
BioF 1 B hamsters fed either seal oil alone or a combination of seal oil and elderberry 
extract. Hence, our findings suggest that elderberry extract supplementation proved more 
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effective in lowering the extent of lipid peroxidation in fish oil fed BioFlB hamsters 
partly due to an increased susceptibility to oxidative stress in fish oil fed BioFlB 
hamsters. Seal oil fed BioFlB hamsters, however being relatively resistant to diet 
induced oxidative stress, showed no significant differences on plasma and lipid 
peroxidation levels upon supplementing with elderberry extract. 
The ability of anthocyanins to inhibit oxidation of lipids (Ramirez-Tortosa eta/., 
2001) and LDLs (Vinson et al. , 1995; Kano eta/. , 2005; Chang et al. , 2006) has mostly 
been reported based on in vitro studies. Y oudim et al. (2000) demonstrated increased 
protection against oxidative stress due to increased incorporation of elderberry 
anthocyanins into the membrane and cytosol of vascular endothelial cells. However, there 
are a few reports on the beneficial effects of anthocyanins against oxidative stress in-vivo. 
Acylated anthocyanins from dietary cabbage proved their anti-oxidant potential by 
preventing paraquat induced oxidative stress in rats (Igarashi eta/. , 2000). Moreover, rats 
fed anthocyanin-rich purple potato flakes showed improved anti-oxidant potential with 
significantly reduced serum lipid peroxidation and elevated mRNA expression of anti-
oxidant enzymes (Han et al. , 2006; Han et al. , 2007). In this study, we report the 
protective effects of anthocyanin-rich elderberry extract in fish oil fed BioFlB hamsters, 
with significantly reduced levels of plasma and liver peroxidation levels, as compared to 
fish oil fed BioF 1 B hamsters. In the future, it will be relevant to study the mechanisms of 
action of anthocyanin rich elderberry extract by measuring enzyme activity and mRNA 
expression of different anti-oxidant enzymes. 
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4.4 Conclusions and future directions 
Previous studies from our laboratory have shown severe hyperlipidemia with 
increased TG and cholesterol concentrations in fish oil fed BioFlB hamsters (de Silva et 
al., 2004). Diet induced hyperlipidemia was further shown to be specific for fish oil when 
compared to MUFA and ro-6/ ro-3 diets, and specific to BioFlB hamsters when compared 
to Golden Syrian hamsters. Molecular studies to compare the two strains of hamsters 
showed significantly lower LPL activity, adipocyte LPL mRNA levels and elevated 
ApoB expression in BioFlB hamsters compared to Golden Syrian hamsters (Cheema and 
Cornish, 2007). These differences partially attribute the fish oil induced hyperlipidemia 
to genetic diversity in the hamster strains. 
In the current study, we showed that an alternative ro-3 PUFA-rich source, seal 
oil, did not cause hyperlipidemia at high doses as seen with fish oil feeding in BioFlB 
hamsters. Seal oil feeding showed significantly lower plasma and liver lipid levels in 
comparison to the fish oil diet. In the future, it will be interesting to investigate the 
regulation ofLPL expression and activity in the BioFIB hamsters fed seal oil and fish oil. 
The differences in the positional distribution of ro-3 PUF A in the TG of the two marine 
oils might potentially confer better TG clearing capacity in seal oil fed BioF 1 B hamsters 
as compared to fish oil fed BioFlB hamsters. It further needs to be investigated whether 
the anti-hypertriglyceridemic effects of seal oil are exclusively due to the differences in 
ro-3 PUF A composition and positional distribution of fatty acids in the triglyceride 
molecule of two oils or is it partly also due to increased MUF A levels or an as yet 
unidentified antioxidant in seal oil. In vitro assays to react commercial LPL with CM 
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from marine oil fed hamsters will help elucidate whether there is greater resistance to 
LPL in case of fish oil CM compared to seal oil CM. Transgenic studies targeting LPL 
gene expression in fish oil and seal oil fed animals will help shed more light on the 
importance of the differences in the positional distribution of co-3 PUF A in the two oils 
on the regulation of lipid metabolism. 
Supplementation of dietary fish oil and seal oil, along with elderberry extract in 
BioF 1 B hamsters, resulted in significant reductions in weight gain at the end of the 4-
week study period as compared to BioF1B hamsters on fish oil or seal oil alone. 
Moreover, co-supplementation of fish oil and seal oil with elderberry extract showed 
significantly improved plasma lipid profile for both dietary fats in BioF1B hamsters. 
Further, comparing the effects of elderberry supplementation on lipid peroxidation levels 
in plasma and liver revealed significant reductions in oxidative stress in fish oil fed 
hamsters, while no significant changes were observed for seal oil fed BioF1B hamsters. 
Thus, anthocyanins showed immense potential in improving lipid profile as well as the 
extent of lipid peroxidation in fish oil fed BioF1B hamsters. However, the mechanisms 
by which anthocyanins, alone or in combination with marine oils, elicit these effects are 
not known, which should be undertaken in the future. 
This study shows that BioF1B hamsters fed high seal oil diet resist hyperlipidemia 
and oxidative stress as compared to fish oil fed BioF1B hamsters. While we believe that 
differences in co-3 PUF A composition and positional differences in TG from two marine 
oils are likely responsible for the differences in the regulation of lipid and lipoprotein 
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metabolism, the differences in fatty acid composition of the two marine oils might also 
play an important role, which could be a topic for future investigations. 
Overall, findings from the present study suggest that seal oil may be better than 
fish oil to lower plasma lipid levels and to prevent oxidative stress under genetically 
variable conditions. Our findings further suggest that co-supplementation of fish oil with 
anthocyanin rich berry extract may be beneficial under these conditions than fish oil 
alone. 
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